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Sandra M. Huenink, O.D. 
PILOT STUDY OF A METHOD TO OBJECTIVELY MEASURE ASTHENOPIA 
SYMPTOMS  
Asthenopia is a commonly encountered clinical diagnosis in the pre-presbyopic 
demographic.  With the increasing number of hours per day of computer and digital device usage 
in the population, its prevalence has been increasing.  Asthenopia is defined to encompass a 
broad range of symptoms, which may be summarized in two categories: eyestrain due to 
accommodative or convergence dysfunction, or eyestrain as a manifestation of dry eye.  While 
these categories are not mutually exclusive, treatment of asthenopia has historically been limited 
to the use of spectacle lenses to alleviate accommodative stress during near activities, and the 
isolated treatment of dry eye symptoms. New technologies in contact lens designs have been 
found to achieve asthenopia symptom relief based off subjective symptom surveys. The pilot 
study presented in this thesis presents a method of inducing asthenopia symptoms while 
objectively measuring the ocular response to the induction stimulus.  This method may be 
performed while a contact lens is worn. Conceptually, this study was designed to explore a 
method that may be used in future research to investigate the in-vivo efficacy of anti-fatigue 
treatments (e.g. contact lenses) in an objective, rather than subjective, capacity. The results of 
this pilot project demonstrate the most promising method for future research involves testing 
with a small-font stimulus. 
 
 
 vi 
 
Table of Contents 
1. Introduction ………………………………………………………………………………..…...1 
2. Literature Review ……………………………………………………………….......................4 
3. Methodology ………………………………………………………………………………….17 
4. Results ………………………………………………………………………………………...31 
5. Discussion ………….………………………………………………………………………..125 
6. Conclusions ………………………………………………………………………………….151 
7. Appendix 1: Case Report Forms ………………………………………………………….....152 
8. Appendix 2: Questionnaires ………………………………………………………………....182 
9. Appendix 3: Operating Procedures for Testing Stimulus …………………………………...187 
10. Appendix 4: Operating Procedures for GoPro Hero 4 Silver Edition .…………………….195 
11. Appendix 5: Font Size Calculation …………………………………………………...……199 
12. Appendix 6: Distance Pre-Test and Post-Test Graphs ……………………………….....….200 
13. Appendix 7: Binocular and Monocular Post-Test Graphs …………………………..…..…208 
14. Curriculum Vitae 
 
 
 
 vii 
 
Supplemental Materials 
Figures 
Figure 1 – Snellen Letter E Calibrated for Microdisplay ……………………………………….22 
Figure 2 – Testing Stimulus: Mahjong Game Screen …………………………………………...22 
Figure 3 – Schematic of COAS and Optics Table Set Up ………………………………………23 
Figure 4 – Repeated Latin Square ……………………………………………………………...128 
Figure 5 – Schematic of the Expected Pattern of Ocular Fatigue in a Flipper Task……………137 
Figure 6 – Schematic of the Expected Pattern of Ocular Fatigue in a Close Working Distance or 
Small Font Task ………………………………………………………………………………..137 
Figure 7 – Examples of COAS Wavefront Images …………………………………………….143 
 
 
 
 
 
 
 viii 
 
Tables 
Table 1 – Biofinity Contact Lens Specifications ………………………………………………..20 
Table 2 – Contact Lens Powers Utilized ………………………………………………………...20 
Table 3 – Randomization ………………………………………………………………………..28 
Table 4 – ANOVA Table for Repeated Latin Square …………………………………………...30 
Table 5.1 – NITBUT Across Subjects by Induction Technique Order …….…..………………..31 
Table 5.2 – NITBUT Across Subjects by Induction Technique Order ANOVA Results ...….…32 
Table 6.1 – NITBUT Across Subjects by Induction Technique Type …………………….…….32 
Table 6.2 – NITBUT Across Subjects by Induction Technique Type ANOVA Results ……….33 
Table 7 – Two-Tailed Paired T-Test for Severity Scale Scores ……………………...…………38 
Table 8 – ANOVA Test Results for Severity Scale Scores ……………………..………………39 
Table 9 – One-Sample Two-Tailed T-Test for Refractive State Error Slopes ……………….....85 
Table 10 – ANOVA Test Results for Total Variance ……………………………….…………..86 
Table 11 – ANOVA Test Results for Change in Variance ………………………….…………..88 
Table 12 – One-Sample Two-Tailed T-Test for Spherical Aberration Slopes ………………...101 
Table 13 – One-Sample Two-Tailed T-Test for Pupil Size Slopes ……………………………113 
 ix 
 
Table 14 – ANOVA Test Results for Change in Variance (by Condition Type) ……………...116 
Table 15 – ANOVA Test Results for Change in Variance (by Condition Order) ……….…….117 
Table 16 – Two-Tailed Paired T-Test for Fissure Height ……………………………………...122 
Table 17 – Correlation Coefficient between Refractive State Error and Fissure Height ………123 
Table 18 – Coefficient of Determination between Refractive State Error and Fissure Height...124 
Table 19 – ANOVA Table for Latin Square ………..………………………………………….127 
Table 20 – Biofinity Sphere Right Eye Contact Lens Powers Utilized ………………..………139 
Table 21 – Comparison of Mean Spherical Aberration Values ………………………………..140 
Table 22 – Binocular Baseline Data Captured …………………………………………..……..144 
Table 23 – Close Working Distance Time to Fatigue and Subjective Eyestrain Results………146 
Table 24 – Binocular Flippers Capture Rate ……………………………………….…..…..…..148 
Table 25 – Close Working Distance Capture Rate ………………..………………...…...…….149 
 
 
 
 
 x 
 
Graphs 
Graphs 1.1-1.4 – Severity Scale Data (by Induction Type) ………………………………….34-35 
Graphs 1.5-1.8 – Severity Scale Data (by Induction Order) ……………………...…...…….36-37 
Graphs 2.1-2.8 – Change in Severity Scale Graphs (by Participant) .………...……………..40-47 
Graphs 3.1a-f – 3.8a-f – Refractive State versus Time (by Participant) …….…………..….49-72 
Graphs 4.1-4.8 – Refractive State Average Error Across Conditions ……...………………..74-81 
Graphs 5.1-5.6 – Refractive State Error Across Participants …………………...…….……..82-84 
Graph 6.1 – Total Variance Across Participants………………………………...........................86 
Graph 6.2 – Change in Variance Across Participants…………………………...........................87 
Graph 7.1-7.8 – Average Spherical Aberration ……………………………………………...89-92 
Graph 8.1-8.8 – Spherical Aberration versus Time (by Participant) ………………………...93-97 
Graph 9.1-9.6 – Spherical Aberration Across Participants …………………………...……98-100 
Graph 10.1-10.8 – Spherical Aberration versus Pupil Size ……………………………….102-105 
Graph 11.1-11.8 – Pupil Size versus Time (by Participant) ………………………………106-109 
Graph 12.1-12.6 – Pupil Size Across Participants ………………………………………...110-112 
Graph 13.1 – Average Time to Fatigue (by Condition Type) …………………………………114 
Graph 13.2 – Average Time to Fatigue (by Condition Order) …………….…………………..115 
 xi 
 
Graph 14.1-14.8 – Fissure Height Across Conditions …………………………………….118-121 
Graph 15 – Copy of Graph 3.4d with Illustration of Incorrect Accommodative Response..…..135 
Graph 16 – Copy of Graph 3.2e with Illustration of Accommodative Response……………...136 
 
 1 
 
Introduction 
“My eyes feel like they’re pulling.”  “I have headaches when I use my computer.” “I get 
tired when I read.” 
One of the most common complaints from young adults heard by optometrists is of 
eyestrain.  Better defined as asthenopia, it encompasses a broad range of symptoms that may 
include dry eyes, fatigue, eye strain or pain, headaches, blurry vision, and diplopia.1 In a study of 
609 18-39 year old adults taking part in a clinical response survey from the Indiana University 
School of Optometry’s Clinical Optic Research Laboratory, over 25% of subjects reported eye 
fatigue (defined as “physical discomfort of their eyes after spending periods of time throughout 
the day in front of a digital screen”) at least once per day, and 50% reported eye fatigue more 
than once per week.2,3  These two figures correlate with my clinical experience, where 
approximately one third of my patients under the age of 35 present with symptoms related to 
asthenopia. The high prevalence of asthenopia is related to the changing landscape of digital 
device usage. As early as 1979, studies analyzing asthenopic symptoms of visual display unit 
operators were underway.4 By 2011, 96% of working American adults were using new 
communications technologies, for example, the internet, as an “integral part of their job.”5 
Today, computer screens, tablets, and smartphones are not just used in schools and the 
workplace, but for leisure activities as well.  A 2014 Nielsen Report found that the average 
                                                          
1 Sheedy JE, Hayes J, Engle J. Is All Asthenopia the Same? Optometry and Vision Science. 2003 Nov. 80(11): 732-
739. 
2 Kollbaum P and Meyer D. Doctor, My Eyes…Are Tired! Review of Optometry. May 15, 2016. 
https://www.reviewofoptometry.com/article/doctor-my-eyes-are-tired. Accessed August 13, 2017. 
3 Meyer D, Huenink S, Rickert P, Kollbaum P, Chamberlain P. Symptoms associated with eye fatigue in soft contact 
lens wearers. Paper presented at: Annual Meeting of the American Academy of Optometry; October 2015; New 
Orleans, LA, USA. 
4 Stewart, TFM. Eyestrain and Visual Display Units: A Review. Displays. Apr 1979, 1(1): 17-24. 
5 US Department of Commerce. Fact Sheet: Digital Literacy. May 13, 2011. http://2010-
2014.commerce.gov/news/fact-sheets/2011/05/13/fact-sheet-digital-literacy.html. Accessed: April 19, 2017. 
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American adult over age 18 spends an average of 11 hours per day on digital devices.6 A 2016 
Vision Council Survey reported 65% of Americans experience eyestrain symptoms when using 
digital devices.7 Not everyone has difficulty with an increased use of technology during all hours 
of the day.  But for those who suffer from asthenopia, maintaining a high level of achievement at 
work or school, and keeping an active social presence online can be difficult. 
New technologies are in development to alleviate the symptoms of asthenopia for the pre-
presbyopic population.  In the spectacle market, anti-fatigue low-add progressive addition lenses 
are available, for example, the Hoya Sync and Essilor Eyezen. Studies have shown these 
spectacle lenses to be effective in the clinical management of asthenopia, by alleviating 
accommodative strain.8 However, 2010 estimates from the CDC show that there are over 15 
million contact lenses wearers under the age of 35 in the US alone.9  It would behoove contact 
lens companies to answer this need with a product of their own.  Anecdotal evidence states that 
the use of low-add simultaneous vision contact lens designs are effective in alleviating 
asthenopia symptoms.  Recently, CooperVision released the Biofinity Energys contact lenses 
which have a “digital zone optical design” described as “multiple front-surface aspheric curves 
employed across the entire optical zone, which […] distribute power evenly to simulate more 
positive power in the center of the lens.”10 These contact lenses are marketed to “help with eye 
                                                          
6 Brown, Molly. Nielsen Reports that the Average American Adult Spends 11 Hours Per Day on Gadgets. March 13, 
2015. http://www.geekwire.com/2015/nielsen-reports-that-the-average-american-adult-spends-11-hours-per-day-on-
gadgets/. Accessed: April 19, 2017. 
7 The Vision Council. Eyes Overexposed: The Digital Device Dilemma. 2016. https://visionimpactinstitute.org/wp-
content/uploads/2016/03/2016EyeStrain_Report_WEB.pdf. Accessed October 1, 2017. 
8 Coronis, Timothy. Anti-Fatigue Lenses: Rx for Overworked Eyes. 20/20. June 2010. 
https://www.2020mag.com/article/anti-fatigue-lenses-rx-for-overworked-eyes. Accessed: April 19, 2017. 
9 Centers for Disease Control and Prevention. “Healthy Contact Lens Wear and Care.” January 22, 2015. 
http://www.cdc.gov/contactlenses/fast-facts.html. Accessed: April 13, 2016. 
10 CooperVision. Digital Zone Optics. 2017. https://coopervision.com/practitioner/our-products/contact-lens-
technology/digital-zone-optics. Accessed August 13, 2017. 
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tiredness caused by focusing on digital devices.”11 CooperVision provides studies that report that 
80% of patients surveyed who use digital devices at least 4 hours per day at least 5 days per 
week and self-report symptoms of eye fatigue at least once per week had relief of eye tiredness 
with the Biofinity Energys contact lens.12  However, these and other potential options of 
asthenopia-relieving contact lenses have not been tested in an objective setting; the current 
standard of measure is subjective, that of self-reported surveys.  
Funded by the Clinical Optics Research Laboratory at Indiana University, the pilot study 
presented in this thesis evaluated four methods of artificially inducing asthenopia symptoms in a 
controlled laboratory environment.  The experimental results may be useful in the development 
of a standardized objective method of measuring ocular fatigue with in vivo contact lenses.  
Future studies may be used to determine how effective a contact lens is at reducing the signs and 
symptoms of asthenopia, with a goal of providing additional evidence that low-add multifocal 
contact lenses are a valuable tool for the optometrist in the care of a pre-presbyopic patient 
suffering from asthenopia.  
                                                          
11 CooperVision. Biofinity Energys. 2017. https://coopervision.com/practitioner/our-products/biofinity-
family/biofinity-energys. Accessed August 13, 2017. 
12 Ibid. 
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Literature Review 
The pilot study presented in this thesis explored four methods of inducing asthenopia in a 
controlled environment. Conceptually, the results of this study (determining the most promising 
method of reliably inducing and accurately measuring the induction of asthenopia) could then be 
repeated in a scenario with an optical aid designed to reduce the time to, and extent of, 
asthenopia symptoms.  Therefore, knowledge of what is expected to cause asthenopia symptoms, 
as well as what is expected to alleviate those symptoms, must be well understood before a 
system may be designed to measure these criteria.   
The following paragraphs review current knowledge of asthenopia, how it relates to 
accommodative disorders and dry eye, as well as reviewing clinical tests used to diagnose and 
the optical technologies used to treat the condition.  Lastly, successful asthenopia induction 
procedures as presented in past literature will be reviewed. 
Though it is a common ailment, asthenopia is not well understood.  As pointed out nearly 
a decade apart by Watten and by Sheedy, the mechanism which results in the symptoms of 
asthenopia are not known. 13,14 Research has been ongoing since the early 1900s to determine if it 
is truly possible to fatigue the ciliary and extraocular musculature, or if the symptoms of “strain” 
or “visual fatigue” are actually interpretations of discomfort from other ocular structures.15  
Asthenopia is most likely the result of a wide variety of causative factors which present with 
remarkably similar symptomatology.  The Mayo Clinic lists the following as examples which 
may induce asthenopia: looking at digital device screens, reading for long periods of time, 
                                                          
13 Watten RG. Reinvention of Visual Fatigue: accumulation of scientific knowledge or neglect of scientific history? 
Ophthalmic and Physiological Optics. 1994 Oct. 14(4):428-432. 
14 Sheedy JE, et al. Is All Asthenopia the Same? 
15 Watten RG. Reinvention of Visual Fatigue. 
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driving or performing tasks that require focusing eyes for long periods of time, bright sunlight or 
glare, straining to see in dim illumination, exposure to dry moving air (e.g. from a fan, heater, or 
air conditioner), dry eyes, uncorrected refractive error, stress, and fatigue.16 One can infer from 
this list that the primary causes of asthenopia involve two groups of ocular problems: (1) 
difficulty with near work, which in the pre-presbyopic demographic is often associated with 
accommodative dysfunction, and (2) dry eye related issues.  
Accommodative disorders in pre-presbyopic individuals can be separated into five 
subgroups: accommodative insufficiency, accommodative infacility, ill-sustained 
accommodation, paralysis of accommodation, and accommodative spasm.17 The first three types 
are relevant to this thesis, as symptoms of each may be alleviated with the proposed contact lens 
modality. 
As defined by the American Optometric Association, accommodative insufficiency 
occurs “when the amplitude of accommodation is lower than expected for the patient’s age, and 
is not due to sclerosis of the crystalline lens.”18 Symptoms of accommodative insufficiency are 
like those reported by emerging presbyopes: of straining and squinting to see clearly at a near 
working distance, or of simple near blur. Accommodative infacility occurs when “the 
accommodative system is slow in making a change, or when there is a considerable lag between 
the stimulus to accommodation and the accommodative response.”19 For example, patients with 
accommodative infacility report blurry vision at distance after periods of near work, and vice 
                                                          
16 Mayo Foundation of Medical Education and Research. Disease and Conditions: Eyestrain. August 13, 2015. 
http://www.mayoclinic.org/diseases-conditions/eyestrain/basics/causes/con-20032649. Accessed April 13, 2016. 
17 Cooper JS, Burns CR, Cotter SA, Daum KM, Griffin JR, Scheiman MM. Optometric Clinical Practice Guideline: 
Care of the Patient with Accommodate and Vergence Dysfunction.  American Optometric Association: St. Louis, 
MO. Approved March 20, 1998. Revised 2010. https://www.aoa.org/documents/optometrists/CPG-18.pdf. Accessed 
October 1, 2017.  
18 Ibid.   
19 Ibid. 
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versa. This can be particularly frustrating for students, who must repeatedly switch focus from 
near to distance when taking notes in class. Ill-sustained accommodation occurs when “the 
amplitude of accommodation is within the normal range, but fatigue occurs with repeated 
accommodative stimulation.”20 Patients suffering from this issue may not perceive asthenopic 
symptoms until having need of a short working distance for a long period of time. However, with 
many jobs and hobbies being performed on computers, smart phones, and tablets, ill-sustained 
accommodation can significantly impair a patient’s productivity.   
The final two categories of accommodative dysfunction are not as relevant to this project, 
as they require alternative interventions to treat. Paralysis of accommodation is fortunately rare, 
and presents with symptoms exactly corresponding to that of absolute presbyopia and a complete 
inability to accommodate.21 Some causes are cycloplegic agents (such as those used in a 
diagnostic eye care setting) or as a sequela of trauma to the eye.  Unless explained by either of 
those two, paralysis of accommodation is generally associated with a larger systemic problem, 
such as uveitis or toxicity.22  Lastly, accommodative spasm is defined as “a spasm of the near 
reflex; the result of overstimulation of the parasympathetic nervous system.”23 It is often noted in 
a triad: accommodative excess, convergence excess, and mitotic pupils.  
While asthenopia may be a multifaceted problem, “dry eyes” proves even more so. Dry 
eye symptoms also include a wide variety of presentation, including: foreign body sensation, 
grittiness, sandiness, blurred vision, pain (which may be sharp or a dull ache), and eyestrain.24 
                                                          
20 Ibid. 
21 Ibid. 
22 Walsh FB and Hoyt WF. Walsh and Hoyt’s Clinical Neuro-ophthalmology. 6th ed. Ed Miller NR, Walsh FB, Hoyt 
WF. (Philadelphia: Lippincott Williams & Wilkins), 783-786. 
23 Cooper JS, et al. Optometric Clinical Practice Guideline. 
24 Mayo Foundation of Medical Education and Research. Disease and Conditions: Dry Eye. July 24, 2015. 
http://www.mayoclinic.org/diseases-conditions/dry-eyes/basics/symptoms/con-20024129. Accessed September 27, 
2017. 
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When exploring the causes of dry eye, one must first consider the makeup of the tear film itself.  
Historically, the tear film was considered comprised of three layers: the outermost lipid layer, 
which protects the middle aqueous layer from evaporating, and the inner mucin layer which 
adheres the tears to the surface of the eye.25  Each layer is produced by different glands in and 
around the eye (lipids from Meibomian glands, aqueous from lacrimal and accessory lacrimal 
glands, and mucin from the goblet cells of the conjunctiva).  If any one of these glands 
malfunction, the tear film may be rendered unstable and inefficient. Additionally, the eyelids and 
nasolacrimal drainage system must work in concert to ensure proper in and outflow of tears 
across the surface of the eye.  The 2017 TFOS DEWS II Tear Film Subcommittee revised the 
anatomy of the tear film to a two-layer organization: “a lipid layer overlying a muco-aqueous 
phase.”26 However, the two primary types of dry eye were not revised: aqueous deficient dry eye 
(wherein the aqueous layer is not produced in significant quantities) and evaporative dry eye 
(wherein the lipid layer does not prevent the aqueous layer from evaporating).27  
Regardless of the type of dry eye, inflammation plays a significant role. In aqueous 
deficient dry eye, lymphocyte mediated upregulation of T-cells is found, suggestive of 
autoimmune inflammation.28 Hyperosmolarity of the tear film, found both in aqueous deficient 
and evaporative dry eye, is a consequence of ocular surface stress which in turn activates pro-
inflammatory cytokines.29 Currently, it is not well understood if the inflammation is causative or 
                                                          
25 Foster JB and Lee WB. The Tear Film: Anatomy, Structure, and Function. August 3, 2015. 
https://clinicalgate.com/the-tear-film-anatomy-structure-and-function. Accessed: September 27, 2017. 
26 Craig JP, Nelson JD, Azar DT, Belmonte C, Bron AJ, Chauhan SK, de Paiva CS, Gomes JAP, Hammitt KM, 
Jones L, Nichols JJ, Nichols KK, Novack GD, Stapleton FJ, Willcox MDP, Wolffsohn JS, Sullivan DA. TFOS 
DEWS II Report Executive Summary. The Ocular Surface. 2017 Oct. 15(4):802-812.  
27 Ibid. 
28 Hessen M, Akpek EK. Dry Eye: an Inflammatory Ocular Disease. Journal of Ophthalmic and Vision Research. 
2014 Apr. 9(2): 240-250. 
29 Ibid. 
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a consequence of dry eyes, however, recognition of its presence has helped facilitate effective 
dry eye treatments (such as cyclosporine A and corticosteroids, in addition to the basic 
treatments of artificial tears and lid hygiene techniques).30    
However, not all types of dry eye are intrinsic in origin, with causes relating to the very 
makeup of the tears as they are formed from the various glands.  Dry eye symptoms may 
manifest from extrinsic forces, for instance, a fan or heater blowing dry air onto the face, or 
staring for long periods of time.  It has been estimated that the average number of blinks per 
minute is 12-15, which reduces to 3-4 during prolonged computer work.31  This may be a prime 
example of why dry eyes and asthenopia can be closely linked, particularly in patients who may 
otherwise have a normal tear film.  
When optometrists receive a chief complaint of asthenopia, several tests in addition to the 
typical exam elements are warranted. To explore the patient’s accommodative system, 
measurements in four categories of accommodative ability should be performed.32 First, the 
amplitude of accommodation is measured via the push-up test.  Accommodative facility is 
assessed via lens rock and distance rock tests.  Relative accommodation is determined through 
the negative and positive relative accommodation measurements. Finally, lag of accommodation 
is measured via monocular estimate method retinoscopy, Nott retinoscopy, low neutral 
retinoscopy, or binocular crossed cylinder testing.  
To determine the extent of dry eyes, the most common initial testing is to stain the tears 
with fluorescein dye, observe the cornea for punctate epithelial erosions (PEE, an early sign of 
                                                          
30 Ibid.  
31 Orlando RG. Computer Eye Syndrome. Columbus Ophthalmology Associates. October 20, 2014. Available at: 
http://www.coavision.com/computer-eye-syndrome/. Accessed April 13, 2016.  
32 Goss DA. Ocular Accommodation, Convergence, and Fixation Disparity: A Manual of Clinical Analysis. 2nd ed. 
(Amsterdam: Elsevier, 1995), 135-149. 
9 
 
corneal epithelial compromise, which in the absence of a different inflammatory condition, are 
common with dry eyes33) and measure the tear-break-up-time (TBUT). A TBUT of under 10 
seconds is considered indicative of dry eyes.34 While TBUT has been shown adequate in 
assessing the extent of dry eyes, other testing is available to narrow down the root of the dry eye 
complaints.  Assessment of tear quantity may be conducted via a simple measurement of the 
inferior tear meniscus (a measurement under 0.2 mm is indicative of dry eye)35, or use of 
Shirmer Strips (a reading under 10 mm after 5 minutes is consistent with dry eye) or Phenyl Red 
Thread (if under 10 mm after 15 seconds).36  Tear quality may be determined with tools such as 
the TearLab, which measures tear osmolarity (in mOsm/L) with loss of tear homeostasis 
indicated by a reading over 300 mOsm/L or a difference between readings in each eye over 8 
mOsm/L.37  Another option is the Inflammadry, which detects levels of MMP-9, an 
inflammatory marker found on the conjunctiva, common to dry eye sufferers.38  
However, in contact lens wearing patients, the tear film is already disrupted by the thin 
layer of synthetic material covering the cornea.39  Indeed, contact lens induced dry eye (CLIDE) 
is a common complaint among contact lens wearers.  In a 2005 report, contact lens wearers were 
ten times more likely to have dry eye symptoms than those requiring no refractive correction, 
                                                          
33 McKenzie M and Whitley W. A Closer Look at Corneal Inflammation. Review of Cornea and Contact Lenses. 
November 15, 2012. Available at: http://www.reviewofcontactlenses.com/content/d/irregular_cornea/c/37560/. 
Accessed April 13, 2016. 
34 Johnson ME and Murphy PJ. The Effect of Instilled Fluorescein Solution Volume on the Values and Repeatability 
of TBUT Measurements. Cornea. 2005 Oct. 24(7): 811-817. 
35 Doughty MJ, Lauguzzaman M, Oblak E, Button N. The tear (lacrimal) meniscus height in human eyes: a useful 
clinical measure or an unusable variable sign? Contact Lens and Anterior Eye. 2002 Jun. 25(2): 57-65. 
36 Vashisht S and Singh S. Evaluation of Phenyl Red Thread Test versus Shirmer Test in Dry Eyes: A Comparative 
Study. International Journal of Applied Basic Medical Research. 2011 Jan-Jun. 1(1): 40–42. 
37 TearLab. How Tear Lab Works. 2016. Available at: http://www.tearlab.com/. Accessed April 13, 2016. 
38 RPS. Identify Dry Eye with Inflammadry. 2016. Available at: https://www.rpsdetectors.com/in/products/identify-
dry-eye-with-inflammadry/. Accessed April 13, 2016. 
39 Landers RA. Effect of Contact Lenses on Tear Film Integrity. American Academy of Optometry Abstract. 
October 25, 2007. Available at: http://www.aaopt.org/effect-contact-lenses-tear-film-integrity. Accessed April 13, 
2016. 
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and five times more likely than spectacle wearers.40 Practitioners have become creative over 
years of treating CLIDE patients who desire to continue wearing contact lenses. For instance, 
increased intake of omega-3 fatty acids (which are natural anti-inflammatories), treatment of 
subclinical Meibomian gland disease (such the lid hygiene techniques of warm compresses and 
lid scrubs, as well as off-label use of oral doxycycline or topical azithromycin), use of topical 
lubrication (artificial tears such as Blink Contacts, Opti-Free Rewetting Drops and Refresh 
Contacts are formulated specifically for use concurrent with contact lens wear), treatment of 
underlying allergic conditions (with topical or systemic antihistamines), use of topical anti-
inflammatory agents (such as cyclosporine A or corticosteroids, previously mentioned as 
treatments of the inflammatory component of all dry eyes), and finally, a re-evaluation of the 
contact lenses themselves.41 
Contact lens manufacturers have taken note of the issue.  For example, CooperVision 
Proclear lenses carry the FDA distinction of providing “improved comfort for contact lens 
wearers who experience mild discomfort or symptoms relating to dryness during lens wear.”42  
Though no other contact lens brand carries a similar FDA approval, several other lens options are 
recommended to alleviate some dry eye symptoms. Daily disposable lenses, such as the Alcon 
Dailies Total 1 with its water gradient technology are designed specifically with hydration in 
mind.43  X-Cel’s 2 week replacement lens Extreme H2O 59% is marketed as the “problem solver 
for dryness,” particularly in computer users who experience “reduced visual acuity after 6-8 
                                                          
40 Nichols JJ, Ziegler C, Mitchell Gl, Nichols KK. Self-reported dry eye disease across refractive modalities. 
Investigative Ophthalmology and Visual Science. 2005 Jun. 46(6):1911-4. 
41 Krohn J. How to Address CLIDE. Review of Cornea and Contact Lenses. March 19, 2012. Available at: 
http://www.reviewofcontactlenses.com/content/c/33099/. Accessed April 13, 2016. 
42 CooperVision. Proclear Family. 2016. Available at: http://coopervision.com/contact-lenses/proclear-family. 
Accessed April 13, 2016. 
43 Alcon. Dailies Total 1. 2014. Available at: http://www.dailies.com/products/dailies-total1.shtml. Accessed April 
13, 2016.  
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hours of wear due to lens instability.”44  Bausch+Lomb’s Ultra with MoistureSeal technology is 
advertised to “feel moist and comfortable even after long hours on [your] digital devices.”45  
Often the primary cause(s) of the asthenopic symptoms are subclinical. They may be a 
manifestation of compounding factors, or perhaps by a mechanism we do not yet know. 
Additionally, the combination of mild accommodative disability and dry eyes are not mutually 
exclusive; for instance, a patient straining their accommodative system is also likely to stare, thus 
blinking more infrequently. Nevertheless, the treatment options available do not necessarily cure 
the underlying problem, but may help to alleviate the symptoms enough that eyestrain is no 
longer noticed by the patient.  Unfortunately, as common as asthenopia is, there are not many 
tools available for the optometrist to prescribe.  Most doctors will start with simple 
recommendations such as the 20/20/20 rule (when performing a task that results with eyestrain 
symptoms, every 20 minutes take 20 seconds to look at least 20 feet away), or, if dry eyes appear 
to be concurrent, the use of artificial tears 2 to 3 times per day.   
However, if a true accommodative problem is at fault, specific and targeted treatment is 
warranted. Of the three highlighted accommodative disorders, accommodative infacility is the 
only one in which vision therapy is considered a first line treatment.46 Accommodative 
insufficiency and ill-sustained accommodation are best relieved with a plus add at near.47  
Currently, this is achieved with bifocal spectacles.  Nearly 10 years ago, anti-fatigue progressive 
                                                          
44 X-CEL. Extreme H2O 59% Sphere: the Problem Solving Lens for Patients Who Experience Dryness and 
Discomfort. Available at: https://www.hydrogelvision.com/aspx/lenses/default.aspx?linkid=7. Accessed April 13, 
2016. 
45 Bausch + Lomb. Bausch+Lomb ULTRA contact lenses with MoistureSeal technology. 2016. Available at: 
http://www.bausch.com/our-products/contact-lenses/lenses-for-nearsighted-farsighted/bausch-lomb-ultra-contact-
lenses#.Vw56rZXmrX4. Accessed April 13, 2016.  
46 Goss DA. Ocular Accommodation, Convergence, and Fixation Disparity: A Manual of Clinical Analysis, 150-
163. 
47 Ibid, 135-149. 
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spectacle lenses were introduced specifically for this young demographic of asthenopia sufferers. 
Designs vary among manufacturers, but the concept is the same: a low-add progressive provides 
a small boost of add power for near viewing, which should alleviate asthenopia symptoms due to 
accommodative dysfunction.  Add powers range from +0.40 (Essilor Eyezen 1), +0.53 (Hoya 
Sync 5), +0.60 (Essilor Eyezen 2), +0.75 (KODAK Anti-Fatigue), +0.85 (Essilor Eyezen 3) to 
+0.88 (Hoya Sync 8).  
New technologies in contact lenses have led to advancements in multifocal contact lens 
options. In soft contact lenses, simultaneous vision lens designs (biconcentric, zonal, or aspheric) 
are most prevalent.48,49 The concept behind simultaneous vision is to allow improved 
binocularity at all distances over the alternative of monovision, wherein the non-dominant eye is 
focused for a near point target, separating the two eyes from observing distance and near visual 
stimuli together.  Biconcentric lens designs have two distinct zones, with the central zone being 
corrected for either distance or near.50 These are most often used in a "modified monovision" 
setting (one eye has a center distance lens, the other, center near), achieving improved 
stereovision over a traditional monovision.51 However, the expectation is that a pupil is large 
enough to accommodate both optical zones, providing vision at two distances in the same lens. 
In patients with small pupils, this lens effectively becomes a monofocal lens and the benefit of 
the simultaneous vision lens design is lost.52  The most common zonal design, also called the 
multi-zone concentric design, is a 5-zone lens, starting with a 2 mm diameter distance focus in 
                                                          
48 Plainis S, Atchison DA, Charman WN. Power Profiles of Multifocal Contact Lenses and Their Interpretation. 
Optometry and Vision Science. 2013 Oct. 90(10): 1066-1077. 
49 Toshida H, Takahashi K, Sado K, Kanai A, Murakami A. Bifocal Contact Lenses: History, Types, Characteristics, 
and Actual State and Problems. Clinical Ophthalmology. 2008 Dec. 2(4): 869-877. 
50 Pérez-Prados R, Piñero DP, Pérez-Cambrodí RJ, Madrid-Costa D. Soft Multifocal Simultaneous Image Contact 
Lenses: A Review. Clinical and Experimental Optometry. 2017 Mar. 100(2): 107-127. 
51 Efron N. (Ed). Contact Lens Practice. 3rd ed. (Amsterdam: Elsevier, 2018), 216-219. 
52 Ibid. 
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the center, then alternating near and distance focus in rings extending peripherally.53 Both 
biconcentric and multi-zone concentric designs may provide binocular vision at distance and 
near; however, they do not provide an intermediate range of clear vision.  
Aspheric designs are the only simultaneous vision design contact lenses which provide a 
full-range of vision. Aspheric contact lens designs are achieved by utilizing spherical aberration, 
inducing add power as a function of eccentricity from the center of the lens.54 Higher add powers 
require an increased amount of spherical aberration. However, the cost of this design is of mildly 
decreased focus at all distances due to the presence of the aberrations.55 These multifocal lenses 
are generally marketed to the presbyopic patient, as an alternative to progressive addition 
spectacle lenses, or bifocals.  By inference, it does make sense that a low add multifocal contact 
lens would be a reasonable alternative to anti-fatigue spectacle lenses.  The Biofinity Energys 
falls into the category of a low-add aspheric simultaneous vision contact lens design.56 With 
limited amounts of spherical aberration (due to the low power of the lens), high quality vision at 
all distances should be preserved, while a benefit of a low add power should decrease the 
accommodative demand required during near tasks. In theory, this lens should provide the same 
benefit as the anti-fatigue design spectacle lenses.   
The precedent for exploring asthenopia in an experimental setting was set by Sheedy in 
his 2003 article “Is all Asthenopia the Same?” In his study, eight induction testing conditions 
were explored, including lens flipper, close working distance, small font, dry eye, flickering 
                                                          
53 Eiden SB. Multiple Multifocal Lenses Make It Easy. Review of Optometry. December 15, 2008. Available at: 
https://www.reviewofoptometry.com/article/multiple-multifocal-lenses-make-it-easy. Accessed September 27, 2017. 
54 Pérez-Prados R, et al. Soft Multifocal Simultaneous Image Contact Lenses: A Review. 
55 Ibid. 
56 CooperVision. Digital Zone Optics. 
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light, glare, mixed astigmatism, and upward gaze conditions.57  The lens flipper condition 
activated accommodative stress, while the close working distance condition isolated convergence 
stress by inducing convergence while eliminating the accommodative demand of the task.58 The 
small font condition was intended to require intense focus and concentration on the stimulus 
item; a behavior that is known to result with asthenopia symptoms.59 The dry eye condition 
exploited the known correlation between asthenopia and dry eye,60 while the flickering light, 
glare, mixed astigmatism, and upward gaze conditions required an intense focus similar to the 
small font condition.  All eight induction testing conditions were found to induce asthenopia.  
Exploration of participants’ survey results describing symptoms associated with each induction 
method showed that asthenopia may be divided into two categories: internal asthenopia related to 
stress of the accommodative and/or binocular vision systems (ache, strain, headache) and 
external asthenopia related to stress of ocular surface structures (burning, irritation, tearing, 
dryness).61  Internal symptoms were found to be induced by the close viewing distance, lens 
flipper, and mixed astigmatism conditions.62 External symptoms were induced by dry eye, glare, 
up-gaze, small font, and flickering light conditions.63  
Further exploration on parsing differences between various experimental asthenopia 
induction techniques has focused on the act of squinting, with the conclusion that participants 
squint during testing when the action would feasibly help clear the image.64 That is, the pinhole 
                                                          
57 Sheedy JE, et al. Is All Asthenopia the Same? 
58 Gowrisankaran S, Sheedy JE, Hayes JR. Eyelid Squint Response to Asthenopia-Inducing Conditions. Optometry 
and Vision Science. 2007 Jul. 84(7): 611-619. 
59 Mayo Foundation of Medical Education and Research. Disease and Conditions: Eyestrain. 
60 Ibid. 
61 Sheedy JE, et al. Is All Asthenopia the Same? 
62 Ibid. 
63 Ibid. 
64 Gowrisankaran S, et al. Eyelid Squint Response to Asthenopia-Inducing Conditions. 
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effect resultant from the act of squinting works best for causative factors such as uncorrected 
refractive error or glare, but not for small font, or accommodative and convergence stresses.  
Lastly, it is known that a correlation exists between decreased blink rate and 
asthenopia.65,66,67 Comparison of baseline blink rate to the decreased blink rate seen when a 
participant begins to experience asthenopia may provide an additional objective measure of 
asthenopia induction.  It is likely that decreased blink rate is most associated with the external 
asthenopia symptoms (as defined by Sheedy),68 as decreased blink rate may be related to dry eye.  
The induction tests selected for this pilot study were the lens flipper, close working 
distance, and small font conditions. These were chosen to replicate the successful asthenopia 
induction techniques referenced above, and further parsed on the expected capability of the 
COAS aberrometer to capture data on defocus and pupil size during the induction task.69 The 
measurement of defocus provides the most compelling data to suggest whether asthenopia is 
induced, and, in the future, may be used to show if a participant is utilizing an add boost in a 
contact lens. As it is expected that as a participant fatigues during testing, tonic accommodation 
is reduced; therefore, via comparison to baseline testing, the defocus measurement may provide 
objective proof that asthenopia was (or was not) induced. 70 Data on pupil size may also be 
collected by the COAS; its usefulness related to the involuntary triad of accommodation, 
convergence, and miosis.  The theory is that pupil size data may be used to infer additional 
                                                          
65 Patel S, Henderson R, Bradley L, Galloway B, Hunter L. Effect of visual display unit use on blink rate and tear 
stability. Optometry and Vision Science. 1991 Nov. 68(11):888-892. 
66 Kollbaum P and Meyer D. Doctor, My Eyes…Are Tired! 
67 Gowrisankaran S, Nahar NK, Hayes J, Sheedy JE. Asthenopia and blink rate under visual and cognitive loads. 
Optometry and Vision Science. 2012 Jan. 89(1):97-104. 
68 Sheedy JE, et al. Is All Asthenopia the Same? 
69 Neal D and Voss LB. Wavefront Sciences Optics and Instrumentation Complete Ophthalmic Analysis System 
User’s Manual Version 1.44.07. January 10, 2006. 
70 Hasebe S, Graf EW, Schor CM. Fatigue Reduces Tonic Accommodation. Ophthalmic and Physiologic Optics. 
2001 Mar. 21(2):151-60. 
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information on accommodation and convergence. However, the relationship between diopters of 
accommodation, amount of vergence and pupil size is not necessarily linear or consistent.71,72 
With such variability, this measurement will not be investigated in this thesis. 
Utilizing knowledge gained from past studies on the topic, the purpose of this thesis is to 
create a method of objectively measuring accommodative status (via objective measurements of 
accommodative demand and response) and tear film stability (via objective measurements of dry 
eye) with in vivo contact lenses. This method may then be applied to determine if a contact lens 
marketed to treat asthenopia is effective at relieving accommodative strain and moderating dry 
eye.   
                                                          
71 Kasthurirangan S and Glasser A. Age Related Changes in the Characteristics of the Near Pupil Response. Vision 
Research. 2006 Apr. 46(8-9):1393-1403. 
72 Ripps H, Chin NB, Siegel IM, Breinin GM. The effect of pupil size on accommodation, convergence and the 
ACA ratio. Investigative Ophthalmology. 1962 Feb. 1(1): 127-135. 
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Methodology 
The study design was created to pilot test a system by which asthenopia could be 
reproducibly induced and monitored in a research setting.   
Four induction techniques were selected, to explore which provided the most efficient 
and repeatable induction of asthenopia that could be monitored in real-time by the COAS 
aberrometer. Multiple baseline tests were captured, to allow for analysis within each subject as 
well as between subjects. Testing of subjective participant responses were procured, to allow 
assessment of correlation between objective and subjective testing results. Finally, measures of 
possible confounding factors, such as dry eye, were evaluated throughout the testing scenarios.   
This experiment was performed in two parts: the first visit was a screening-visit to 
determine a participant’s candidacy for the second, study-visit.  Case report forms for the two 
visits may be found in Appendix 1.   
Each participant consented to participate in the study per a protocol approved by the 
Indiana University Institutional Review Board. The participants were recruited from the student 
body at the Indiana University School of Optometry, selected via the following criteria:  
Inclusion Criteria: 
• Has received an oculo-visual examination in the last two years 
• Is between 18 and 35 years of age with full legal capacity to volunteer  
• Has read and understood the informed consent letter 
• Is willing and able to follow instructions and maintain the appointment schedule 
• Is correctable to a visual acuity of 20/25 or better (in each eye) with their habitual 
correction or 20/20 best corrected 
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• Currently wears soft contact lenses between -0.50 D and -6.00 D 
• Has a spherical Contact Lens Rx between -0.50 and -6.00 and spectacle cylinder <-0.75 
• Has not worn lenses for at least 12 hours before the examination 
• Is symptomatic of eyestrain; self-reports symptoms at a frequency equal to or greater than 
1x/week (as determined by Eye Fatigue Experiences Questionnaire, see Appendix 2) 
Exclusion Criteria: 
• Has never worn contact lenses before 
• Has any systemic disease affecting ocular health 
• Is using any systemic or topical medications that will affect ocular health 
• Has any ocular pathology or anomaly that would affect the wearing of the contact lenses 
• Has any dry eye signs and/or symptoms (CLDEQ-8 total of ≥12, see Appendix 2; Non-
invasive TBUT<10 seconds, confirmed after 3 measurements averaged together) 
• Has persistent, clinically significant corneal or conjunctival staining using sodium 
fluorescein dye 
• Is aphakic 
• Has uncorrected anisometropia of >2.00 
• Has undergone corneal refractive surgery 
• Is participating in any other type of eye related clinical or research study 
Each participant read and signed an Informed Consent Statement, an Authorization for 
the Release of Health Information for Research form, and an agreement to be compensated at a 
rate of $40.00/hour rounded to the nearest 0.25 hour for the two visits required to complete 
participation in the study.  
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The primary objective of the screening-visit was to ensure that study participants did not 
have any pre-existing medical, binocular vision, dry eye or refractive problems that would 
confound the data collected in the study-visit.  This was confirmed by careful measurement of 
the participant’s refractive state before and after cycloplegia, by a thorough anterior segment 
ocular health examination, and by evaluation of the binocular vision system.  Baseline results on 
the non-invasive tear break up time and Eye Fatigue Rating Questionnaire (EFRQ, see Appendix 
2) were also obtained, which could then be compared to the same results collected at the study-
visit. 
Materials required for the screening-visit included:  
• Ocular examination lane with typical equipment: slit lamp for biomicroscopy, 1% 
Tropicamide eye drops, sodium fluorescein ophthalmic strips, Phoropter for refractive 
and binocular vision testing, auto-refractor/auto-keratometer, retinoscope, PD stick, 
visual acuity chart (traditional Snellen letters on projector screen, and Sloan optotypes on 
LogMAR high intensity/high contrast acuity chart at 4m and 40cm), photometer to 
measure room luminance/illuminance in cd/m2 
• Medmont E300 Corneal Topographer to perform non-invasive tear break up time 
measurements 
The study-visit design was to place the participant into scenarios that would induce 
symptoms of asthenopia (as defined by the EFRQ)73,74 while objectively measuring via the 
COAS aberrometer the defocus and pupil size of the participant’s right eye.   
                                                            
73 Meyer D, et al. Symptoms associated with eye fatigue in soft contact lens wearers. 
74 Kollbaum PS, Meyer D, Huenink S, Rickert M, Chamberlain P, Hall L. Digital Device User Survey of Eye 
Fatigue. Paper presented at: Association for Research in Vision and Ophthalmology; May 2016; Seattle, WA, USA. 
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Materials required for the study-visit included: 
• Biofinity contact lenses, see Table 1: 
Table 1 
Biofinity Contact Lens Specifications 
Manufacturer CooperVision 
Material Comfilcon A 
Base Curve (mm) 8.6 
Diameter (mm) 14.0 
Power (D) -0.50 to -6.00 
Add n/a 
Wear regimen Daily Wear 
Spherical 
Aberration (µm)75 
-0.31 
Table 2 
Contact Lens Powers Utilized 
Participant Right eye (D) Left eye (D) 
01 -2.50 -2.25 
03 -4.25 -4.50 
05 -1.25 -2.00 
06 -2.00 -1.75 
07 -2.25 -2.00 
08 -2.75 -2.75 
09 -4.25 -4.25 
10 -1.50 -2.00 
 
                                                            
75 Altoaimi BH, Almutairi MS, Kollbaum P, Bradley A. Accommodative Behavior of Eyes Wearing Aspheric Single 
Vision Contact Lenses. Optometry and Vision Science. 2017 Oct. 94(10): 971-980. 
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• Optics table with affixed ruler and mount to keep stimulus items at chosen test distances, 
with bite bar stabilization to hold all participants and equipment steady in testing 
configuration 
• Wavefront Sciences COAS Aberrometer to provide real-time measurements of 
accommodative status during testing scenarios76 
• GoPro Hero 4 silver edition camera with custom mount to place camera at a 22 cm 
working distance from the participant’s pupil plane 
• Equipment for testing stimuli: microdisplay for baseline testing, iPhone 4, MacBook Pro 
laptop with external Apple Magic TrackPad 
• Software for testing stimuli: calibrated Snellen “E” to provide 2M visual stimulus at a 
distance target of 200 cm for baseline distance testing (Figure 1), Mahjong Solitaire Epic 
HD v2.2.1 Application by Kristanix Games as testing stimuli at near (tiles set to letters in 
the English alphabet and numbers rather than characters or symbols, for examples see 
Figure 2), TeamViewer Remote Control Application to mirror the Mahjong game screen 
onto the iPhone, while being controlled by the participant on the MacBook Pro via the 
external Apple Magic TrackPad  
 
 
 
 
                                                            
76 Neal D and Voss LB. Wavefront Sciences Optics and Instrumentation Complete Ophthalmic Analysis System 
User’s Manual. 
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Figure 1 
Snellen Letter E Calibrated for Microdisplay 
 
Figure 2 
Testing stimulus: Mahjong Game Screen 
 
• Asthenopia Induction testing equipment: +0.50 DS trial lens for distance testing (needed 
to optically create the 2 M stimulus item), eye patch for monocular testing scenarios,         
-3.00 DS lens flipper for binocular flipper condition, -3.00 DS trial lens for monocular 
flipper condition, +5.00 DS spectacles to eliminate accommodative demand for the close 
working distance (20 cm) condition, timer to track testing time up to maximum 15 
minutes 
A schematic of the COAS and optics table organization may be seen in Figure 3. 
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Figure 3 
Schematic of COAS and Optics Table Organization 
 
To accurately quantify each participant’s data, baseline testing was performed on each 
participant before the induction testing began. Binocular distance baseline testing was performed 
at the beginning and end of the study, to measure resting accommodation at optical infinity. A 
single maximum cycle of 43 image captures by the COAS at a frame rate of 2 seconds were 
captured under this condition. This translates to 1 minute 26 seconds in this testing configuration.  
To ensure the accurate display of a 20/20 Snellen letter stimulus item, the 2 M stimulus (Snellen 
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Letter E, see Figure 1) was placed at a distance of 200 cm from the COAS and a +0.50 DS lens 
was placed in the COAS lens well in front of the participant’s right eye. (To subtend a 20/20 
acuity letter size, a 1 M stimulus placed at 1 meter distance would be 1.45 mm in height viewed 
through a +1.00 DS lens; at 2 meters, or 200 cm, the 2 M stimulus would be 2.91 mm in height 
viewed through a +0.50 DS lens.) Additional baseline testing using the study stimulus item 
(Mahjong Solitaire Epic played on the iPhone screen controlled by the MacBook; for the 
operating procedures, see Appendix 3) was performed at the test distance of 40 cm from the 
COAS lens well (spectacle plane of eye), under binocular and monocular conditions. The 
stimulus was presented for the maximum time of 15 minutes, spliced into 10.46 cycles of 43 
COAS image captures. This data could then be compared to each participant’s induction test 
results, to determine if a change to the patient’s accommodative state was created by the test 
scenario. 
High quality image capture of the testing scenarios was performed by video recording 
with the GoPro Hero 4 silver edition camera. The camera was placed at 22 cm from the 
participant’s pupil plane. To ensure accurate measurement during each test, image capture of a 
PD stick placed at the participant’s pupil plane before each testing scenario provided information 
for the conversion of pixels to millimeters to be used in analysis. Analysis of the participant’s 
blink rate could be performed by viewing the video recording and counting blinks.  Standard 
operating procedures for the GoPro Hero 4 may be found in Appendix 4.  
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Non-invasive tear break up time was measured by the researcher using the Medmont 
E300 corneal topographer.77 Instructions given to the participant was to blink three times, then 
hold eyes open wide until they were unable.  The researcher watched the topographer’s mires 
reflected off of the surface of the participant’s contact lens or cornea, for the blurring, or 
disruption of mires to start. Time (seconds) to mire distortion was counted as tear break up 
time.78 This process was repeated 3 times per eye, and results were averaged together to create a 
single value for analysis.  These measures could then be analyzed within subjects and between 
subjects, to rule out dryness of the contact lens as a confounding factor in the testing scenarios. 
At maximum, the participant was allowed 15 minutes to perform each task, but could 
stop the timer at any time once “barely tolerable eyestrain” was achieved.79 Additionally, the 
participant was instructed to stop time if the iPhone screen could no longer be kept clear and 
single (e.g. if insurmountable diplopia or blur were to occur).  If the participant concluded the 15 
minutes, a survey question of “percentage of barely tolerable eyestrain” was asked (see 
Appendix 2). Time at which the participant stopped playing the Mahjong game was recorded, as 
well as the total number of puzzles completed and number of “stars” or game points achieved (up 
to a maximum of 3: completion of board, no hint or shuffle of tiles, and completion time under 
game expectation as programmed into the software) was recorded. To prevent memorization of 
any puzzle, participants never repeated the same puzzle.  All puzzles presented were of same 
level of difficulty.  
                                                            
77 Kojima R, Caroline P, Kinoshita B, Lampa M, André M, Rosen C. Applications of Corneal Topography Beyond 
Corneal Shape. Contact Lens Spectrum. November 1, 2013. Available at: 
http://www.clspectrum.com/issues/2013/november-2013/applications-of-corneal-topography-beyond-corneal. 
Accessed September 3, 2017. 
78 Situ P, Simpson TL, Fonn D, Jones LW. Conjunctival and Corneal Pneumatic Sensitivity is Associated with Signs 
and Symptoms of Ocular Dryness. Investigative Ophthalmology and Vision Science. 2008 Jul. 49(7): 2971-2976. 
79 Sheedy JE, et al. Is All Asthenopia the Same? 
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The EFRQ was presented before testing commenced (the participant was to answer the 
questions based overall or average daily symptoms), after all testing was completed (based on 
severity of symptoms after all study testing was complete), and immediately before and 
immediately after each testing scenario (based on severity of symptoms “right now”). The 
purpose was to have a subjective measure of the participant’s symptoms of asthenopia to 
correlate with the objective measures gathered during the study.  
The four testing conditions, binocular flippers, monocular flippers, close working 
distance, and small font, were selected for this study. The conditions were chosen based on 
successful asthenopia induction procedures presented in past literature, that could be performed 
in the COAS set up.  The first two conditions, binocular and monocular flippers, placed the 
testing stimulus (iPhone) at a 40 cm working distance with a full-screen representation of the 
Mahjong game. In the binocular condition, participants were instructed to begin with the plus-
powered lenses in front of their eyes, and in the monocular condition (with the left eye patched) 
instructed to perform the first matching set on the Mahjong game without the trial lens in place. 
A single match was to be performed with each flip of the lenses, in the binocular condition from 
no lens to -3.00 DS, and in the monocular condition from no lens to -3.00 DS. Before the match 
could be made, the participant was instructed to focus on the iPhone screen so that it appeared 
clear and single. If that was not achievable or if the patient reached a discomfort level of “barely 
tolerable eyestrain,” the participant was instructed to stop time. The design of the third condition, 
close working distance, brought the testing stimulus (iPhone) to a 20 cm working distance. +5.00 
DS spectacles were worn to eliminate the accommodative strain incurred at the test distance. The 
fourth, small font condition task set up returned the iPhone to a 40 cm working distance, but 
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shrank the size of the images on the Mahjong tiles to 1mm in height. This was achieved by 
shrinking the size of the Mahjong game on the MacBook Pro to 4.25 inches x 3 inches.   
Lastly, post-test measures included a repeat of the baseline tests performed. In total, the 
average time required for the study procedure was 1.6 hours for the screening-visit and 3.75 
hours for the study-visit. Two study visits were completed by a total of eight participants (total 
number of participants required to eliminate any order effect within the four asthenopia induction 
testing categories, based on a balanced repeated Latin square randomization design, see Table 
3).80   
 
 
 
 
 
 
 
 
 
 
                                                            
80 Dubcovsky, J. Double Block Designs: Latin Squares. Archive of Experimental Design Course PLS205 (Winter 
2015). Department of Plant Sciences, University of California – Davis. Available at: 
http://www.plantsciences.ucdavis.edu/agr205/lectures/2011_lectures/l7_latinsq.pdf. Accessed September 10, 2017.  
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Table 3 
Randomization 
Key 
Initial 
randomization 
Latin Square 
Order   
1 
Close Working 
Distance 
1 2 4 3  
  
2 
Binocular 
Flippers 
2 3 1 4  
  
3 
Monocular 
Flippers 
3 4 2 1  
  
4 Small Font 4 1 3 2 
  
  
 
  
Subject Induction 1 Induction 2 Induction 3 Induction 4 
1 
Close Working 
Distance 
Binocular 
Flippers Small Font 
Monocular 
Flippers 
2 
Binocular 
Flippers 
Monocular 
Flippers 
Close Working 
Distance Small Font 
3 
Monocular 
Flippers Small Font 
Binocular 
Flippers 
Close Working 
Distance 
4 Small Font 
Close Working 
Distance 
Binocular 
Flippers 
Monocular 
Flippers 
5 
Close Working 
Distance 
Binocular 
Flippers Small Font 
Monocular 
Flippers 
6 
Binocular 
Flippers 
Monocular 
Flippers 
Close Working 
Distance Small Font 
7 
Monocular 
Flippers Small Font 
Binocular 
Flippers 
Close Working 
Distance 
8 Small Font 
Close Working 
Distance 
Binocular 
Flippers 
Monocular 
Flippers 
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COAS aberrometer data was exported and interpreted via established MatLab and 
Microsoft Excel code.81,82  
Statistical analysis was performed via the linear model for the Latin square:83  
 
Where:  
yij(t) represents the outcome variables for each participant 
µ represents the baseline mean for all participants 
βi represents effect of the ith subject order (based on row blocking) 
γj represents the effect of the jth subject order (based on column blocking) 
τt represents the treatment effect 
εij represents random error from the ith row and jth column 
 The test hypothesis was a comparison of Ho: τt = 0 versus Hi: τt ≠ 0. The p-value was set 
to 0.05. 
The ANOVA table for a repeated Latin square analysis may be seen in Table 4:84 
 
 
                                                            
81 Liu, T. Extract Zernike Coeff. Custom MatLab Code. July 2012. 
82 Altoaimi, B. Template for Interpreting Pupil Size, Defocus, and up to 8th order Zernike Coefficient COAS Data 
Output. Custom Microsoft Excel Code. November 2015. 
83 Dubcovsky, J. Double Block Designs: Latin Squares. 
84 Ibid. 
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Table 4 
ANOVA Table for Repeated Latin Square 
Source Df SS MS F 
Rows r – 1 SSR SSR/(r-1) MSR/MSE 
Columns r – 1 SSC SSC/(r-1) MSC/MSE 
Treatments r – 1 SST SST/(r-1) MST/MSE 
Error 2(r-1)(r-2) SSE SSE/(2(r-1)(r-2))  
Total r2-1 TSS     
 
Where: 
df represents degrees of freedom 
SS represents sum of squares 
MS represents mean squares 
F represents the F-statistic 
r represents rows (in this experimental 
design, r = 4, as 4 rows are accounted for; 
see Table 2.)  
SSR represents sum of squares between 
rows 
SSC represents sum of squares between 
columns 
SST represents sum of squares between 
treatments 
SSE represents error sum of squares 
TSS represents total sum of squares 
MSR represents mean square between rows 
MSC represents mean square between 
columns 
MST represents mean square between 
treatments 
MSE represents mean square error 
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Results 
 Four categories of results were extrapolated from the data collected. (1) Non-invasive 
tear break up time; (2) Symptom severity scale; (3) COAS Aberrometer data (including 
refractive state, spherical aberration and pupil size); (4) Go-Pro camera video recording data 
(including time to fatigue and fissure height).  The following tables and graphs represent the 
results in each category, which will be further analyzed in the discussion chapter. 
Non-invasive tear break up time 
Table 5.1 
Change in Non-invasive tear break up time for each condition across subjects (post-test measure 
minus pre-test measure); for induction technique in order of performance, regardless of type 
Participant 
Induction 
Technique 
1 
(seconds) 
Induction 
Technique 
2 
(seconds) 
Induction 
Technique 
3 
(seconds) 
Induction 
Technique 
4 
(seconds) 
01 3.6 -0.3 0.3 0.6 
03 4.3 -2 4.4 -2.7 
05 -3 -2 0.3 -2.3 
06 -6.3 0.6 2.4 -0.3 
07 4.4 1.3 1 1 
08 0.7 0.3 1.7 0.4 
09 0.6 3.7 -4.3 -0.7 
10 -1.7 0 0.7 -1.7 
AVERAGE 0.325 0.2 0.8125 -0.7125 
 
 The negative values here indicate that the post-test tear break up time measurement was 
longer in duration than its corresponding pre-test measure.  Positive values are the opposite: the 
post-test tear break up time measurement was shorter in duration than its corresponding pre-test 
measure. 
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Table 5.2 
ANOVA results 
 
Induction 
Technique 
1 
Induction 
Technique 
2 
Induction 
Technique 
3 
Induction 
Technique 
4 Total 
N 8 8 8 8 32 
∑X 2.6 1.6 6.5 -5.7 5 
Mean 0.325 0.2 0.8125 -0.7125 0.1563 
∑X2 103.24 23.92 48.17 17.57 192.9 
Std Dev 3.8246 0.81361 2.4753 1.3892 2.4895 
Source SS df MS 
Between 9.7263 3 3.2421 
Within 182.3925 28 6.514 
Total 192.1188 31  
F=0.49771 
p=0.686857 
Not Significant @ 
p<0.05 
 
Table 6.1 
Change in Non-invasive tear break up time for each condition across subjects (post-test measure 
minus pre-test measure); induction technique separated by type, regardless of order performed 
Participant 
Monocular 
Flippers 
(seconds) 
Binocular 
Flippers 
(seconds) 
Close 
Working 
Distance 
(seconds)  
Small 
Font 
(seconds) 
01 0.6 -0.3 3.6 0.3 
03 -2.7 -2 -4.3 4.4 
05 -2.3 0.3 -2 -3 
06 0.6 -6.3 2.4 -0.3 
07 1 1 1.3 4.4 
08 0.7 1.7 0.4 0.3 
09 3.7 0.6 -4.3 -0.7 
10 1 0.7 -1.7 0 
AVERAGE 0.325 -0.5375 -0.575 0.675 
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Table 6.2 
ANOVA results 
 
Monocular 
Flippers 
Binocular 
Flippers 
Close 
Working 
Distance 
Small 
Font Total 
N 8 8 8 8 32 
∑X 2.6 -4.3 -4.6 5.4 -0.9 
Mean 0.325 -0.5375 -0.575 0.675 -0.0281 
∑X2 29.48 48.61 64.44 48.48 191.01 
Std Dev 2.0226 2.5718 2.9712 2.5308 2.4821 
Source SS df MS 
Between 9.4209 3 3.1403 
Within 181.5638 28 6.4844 
Total 190.9847 31  
F=0.48429 
p=0.695898 
Not Significant @ 
p<0.05 
 
 The result of p<0.05 in both instances (tables 5.2 and 6.2) indicate no correlation between 
signs and symptoms of dry eye seen throughout any of testing conditions, regardless of test order 
or type.  
Symptom Severity Scale 
The following eight graphs represent the mean change in symptom scores across 
participants for the symptom severity scale survey data collected.  This was determined by 
calculating the change in each symptom score (post-test symptom score minus pre-test symptom 
score) for each participant and condition type, and calculating the average across participants for 
that condition and symptom.  Graphs 1.1 through 1.4 represent the severity scale data analyzed 
by induction type, regardless of condition order performed. Graphs 1.5 through 1.8 represent the 
severity scale data analyzed by induction testing order, regardless of testing type.  
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Graph 1.1 
 
Graph 1.2 
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Graph 1.3 
 
Graph 1.4 
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Graph 1.5 
 
Graph 1.6 
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Graph 1.7 
 
Graph 1.8 
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 A two-tailed paired T-Test to determine if any difference in pre- and post-test severity 
scale scores were due to chance was performed for each participant in each condition. These 
results may be seen in Table 7. 
Table 7 
Two-tailed paired T-Test for two dependent means; Ho (that any difference in pre-and post-test 
severity scale scores are due to chance) is rejected if p<0.0125 
(Bonferroni correction was utilized to determine the p-value: alpha of 0.05 divided by 4 
induction testing categories equals new p-value of 0.0125. The Blue data in the following graph 
represents non-significance at p>0.0125; Red represents significance at p<0.0125.) 
 
 ANOVA results of change in severity scale scores across participants (Table 8) are found 
below. 
 
 
 
 
Participant
Induction 
Technique 1
Induction 
Technique 2
Induction 
Technique 3
Induction 
Technique 4
Monocular 
Flippers
Binocular 
Flippers
Close 
Working 
Distance 
Small Font
01B 0.02362735 0.22123505 0.05194242 0.03792897 0.03792897 0.22123505 0.02362735 0.05194242
03B 0.43157875 0.05194242 0.79611286 0.05194242 0.05194242 0.05194242 0.43157875 0.79611286
05B insufficent data 0.01619707 0.01114965 0.01114965 0.01114965 0.01114965 0.01619707 insufficent data
06B 0.22123505 0.00160697 0.00031508 0.02609689 0.00160697 0.22123505 0.00031508 0.02609689
07B 0.00114311 0.0003766 0.0095826 0.00155332 0.00155332 0.0095826 0.0003766 0.00114311
08B 0.01619707 0.1668896 0.13989121 0.13989121 0.01619707 0.13989121 0.13989121 0.1668896
09B 0.04554128 0.0251115 0.02415812 0.05194242 0.0251115 0.04554128 0.02415812 0.05194242
10B 0.11127906 3.6426E-05 0.0815534 0.23747165 0.11127906 0.0815534 0.23747165 3.6426E-05
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Table 8 
ANOVA test results; Ho (that any difference in pre-and post-test severity scale scores are due to 
chance) is rejected if p<0.0125 
(Blue represents non-significance at p>0.0125; Red represents significance at p<0.0125.  In this 
case, the Bonferroni corrected p-value and the standard alpha of 0.05 have the same number of 
significant outcomes.) 
Small Font   P = 0.388 
Close Working 
Distance P = 0.003 
Binocular Flippers P = 0.000 
Monocular Flippers P = 0.000 
Induction Technique 1 P = 0.968 
Induction Technique 2 P = 0.000 
Induction Technique 3 P = 0.009 
Induction Technique 4 P = 0.000 
 
 As may be seen by the large number of significant results, much of the mean change in 
severity scale symptom scores are not due to chance.  This was further explored by comparing 
the change in severity scale (post-test results minus pre-test results) for each participant in each 
condition.  The following graphs (organized by participant) highlight what is occurring 
throughout the testing scenarios, with colored dots representing the change in severity scale 
results during the testing conditions. A value of zero indicates no change in score, positive values 
indicate a worsening of symptoms, and negative values indicate an improvement to symptoms.  
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Graph 2.1 
Participant 01 Change in Severity Scale Graph 
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Symptom
01 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Close Working Distance
Change in Severity Scale, Induction Type 2: Binocular Flippers
Change in Severity Scale, Induction Type 3: Small Font
Change in Severity Scale, Induction Type 4: Monocular Flippers
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Graph 2.2 
Participant 03 Change in Severity Scale Graphs 
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Symptom
03 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Close Working Distance
Change in Severity Scale, Induction Type 2: Binocular Flippers
Change in Severity Scale, Induction Type 3: Small Font
Change in Severity Scale, Induction Type 4: Monocular Flippers
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Graph 2.3 
Participant 05 Change in Severity Scale Graphs 
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Symptom
05 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Small Font
Change in Severity Scale, Induction Type 2: Close Working Distance
Change in Severity Scale, Induction Type 3: Binocular Flippers
Change in Severity Scale, Induction Type 4: Monocular Flippers
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Graph 2.4 
Participant 06 Change in Severity Scale Graphs 
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Symptom
06 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Binocular Flippers
Change in Severity Scale, Induction Type 2: Monocular Flippers
Change in Severity Scale, Induction Type 3: Close Working Distance
Change in Severity Scale, Induction Type 4: Small Font
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Graph 2.5 
Participant 07 Change in Severity Scale Graphs 
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Symptom
07 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Small Font
Change in Severity Scale, Induction Type 2: Close Working Distance
Change in Severity Scale, Induction Type 3: Binocular Flippers
Change in Severity Scale, Induction Type 4: Monocular Flippers
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Graph 2.6 
Participant 08 Change in Severity Scale Graphs 
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Symptom
08 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Monocular Flippers
Change in Severity Scale, Induction Type 2: Small Font
Change in Severity Scale, Induction Type 3: Binocular Flippers
Change in Severity Scale, Induction Type 4: Close Working Distance
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Graph 2.7 
Participant 09 Change in Severity Scale Graphs 
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Symptom
09 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Binocular Flippers
Change in Severity Scale, Induction Type 2: Monocular Flippers
Change in Severity Scale, Induction Type 3: Close Working Distance
Change in Severity Scale, Induction Type 4: Small Font
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Graph 2.8 
Participant 10 Change in Severity Scale Graphs 
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Symptom
10 Change in Severity Scale Across All Testing 
Conditions
Change in Severity Scale, Induction Type 1: Monocular Flippers
Change in Severity Scale, Induction Type 2: Small Font
Change in Severity Scale, Induction Type 3: Binocular Flippers
Change in Severity Scale, Induction Type 4: Close Working Distance
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COAS Aberrometer Data 
 Refractive state data, spherical aberration and pupil size as captured by the COAS 
Aberrometer was compiled for each participant in each task condition (close working distance, 
binocular flippers, monocular flippers and small font).  Binocular and monocular baseline data 
provided a control for all three subsets of COAS data. The following graphs represent each 
induction technique plus baseline testing compiled onto individual graphs, separated by 
participant.  
Graphs 3.1a-f through 3.8a-f present refractive state versus time. Due to the complex 
nature of this data (defocus data analyzed both as minRMS and central for each condition and the 
varying amounts of expected accommodative stimulus based on condition) these graphs are 
presented below in sets of 6 for each participant (one graph each for binocular baseline, 
monocular baseline, close working distance, binocular flippers, monocular flippers and small 
font).  
This data is then further parsed into analysis of the central refractive data only, as pupil 
size is not a factor in those measurements. Refractive state error is presented in graphs 4.1 
through 4.8, graphs 5.1 through 5.6, and table 9. The variance in the refractive state error is 
presented in graphs 6.1, 6.2 and tables 10 and 11.   
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Graph 3.1a 
Participant 01 Binocular Baseline Refractive State versus Time 
 
 Gaps in the data, such as that found at 500 seconds, were missing due to a combination of 
involuntary data corruption (e.g. when COAS image capture did not provide usable data for 
analysis) and/or voluntary data corruption (e.g. when participants did not follow the instructions 
given by the investigator.) These can be found across conditions and in data from all participants, 
and is explored in depth in the discussion section. 
Graph 3.1b 
Participant 01 Monocular Baseline Refractive State versus Time 
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Graph 3.1c 
Participant 01 Close Working Distance Refractive State versus Time 
 
Graph 3.1d 
Participant 01 Binocular Flippers Refractive State versus Time 
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Graph 3.1e 
Participant 01 Monocular Flippers Refractive State versus Time 
 
Graph 3.1f 
Participant 01 Small Font Refractive State versus Time 
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Graph 3.2a 
Participant 03 Binocular Baseline Refractive State versus Time 
 
Graph 3.2b 
Participant 03 Monocular Baseline Refractive State versus Time 
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Graph 3.2c 
Participant 03 Close Working Distance Refractive State versus Time 
 
Graph 3.2d 
Participant 03 Binocular Flippers Refractive State versus Time 
 
 The location of the flippers (in or out) for participant 3 is data missing at random. The 
video recording file used to determine flipper location was not saved after this trial.  
54 
 
Graph 3.2e 
Participant 03 Monocular Flippers Refractive State versus Time 
 
Graph 3.2f 
Participant 03 Small Font Refractive State versus Time 
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Graph 3.3a 
Participant 05 Binocular Baseline Refractive State versus Time 
 
Graph 3.3b 
Participant 05 Monocular Baseline Refractive State versus Time 
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Graph 3.3c 
Participant 05 Close Working Distance Refractive State versus Time 
 
Graph 3.3d 
Participant 05 Binocular Flippers Refractive State versus Time 
 
 
 
57 
 
Graph 3.3e 
Participant 05 Monocular Flippers Refractive State versus Time 
 
Graph 3.3f 
Participant 05 Small Font Refractive State versus Time 
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Graph 3.4a 
Participant 06 Binocular Baseline Refractive State versus Time 
 
Graph 3.4b 
Participant 06 Monocular Baseline Refractive State versus Time 
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Graph 3.4c 
Participant 06 Close Working Distance Refractive State versus Time 
 
Graph 3.4d 
Participant 06 Binocular Flippers Refractive State versus Time 
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Graph 3.4e 
Participant 06 Monocular Flippers Refractive State versus Time 
 
Graph 3.4f 
Participant 06 Small Font Refractive State versus Time 
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Graph 3.5a 
Participant 07 Binocular Baseline Refractive State versus Time 
 
Graph 3.5b 
Participant 07 Monocular Baseline Refractive State versus Time 
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Graph 3.5c 
Participant 07 Close Working Distance Refractive State versus Time 
 
Graph 3.5d 
Participant 07 Binocular Flippers Refractive State versus Time 
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Graph 3.5e 
Participant 07 Monocular Flippers Refractive State versus Time 
 
Graph 3.5f 
Participant 07 Small Font Refractive State versus Time 
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Graph 3.6a 
Participant 08 Binocular Baseline Refractive State versus Time 
 
Graph 3.6b 
Participant 08 Monocular Baseline Refractive State versus Time 
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Graph 3.6c 
Participant 08 Close Working Distance Refractive State versus Time 
 
Graph 3.6d 
Participant 08 Binocular Flippers Refractive State versus Time 
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Graph 3.6e 
Participant 08 Monocular Flippers Refractive State versus Time 
 
Graph 3.6f 
Participant 08 Small Font Refractive State versus Time 
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Graph 3.7a 
Participant 09 Binocular Baseline Refractive State versus Time 
 
Graph 3.7b 
Participant 09 Monocular Baseline Refractive State versus Time 
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Graph 3.7c 
Participant 09 Close Working Distance Refractive State versus Time 
 
Graph 3.7d 
Participant 09 Binocular Flippers Refractive State versus Time 
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Graph 3.7e 
Participant 09 Monocular Flippers Refractive State versus Time 
 
Graph 3.7f 
Participant 09 Small Font Refractive State versus Time 
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Graph 3.8a 
Participant 10 Binocular Baseline Refractive State versus Time 
 
Graph 3.8b 
Participant 10 Monocular Baseline Refractive State versus Time 
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Graph 3.8c 
Participant 10 Close Working Distance Refractive State versus Time 
 
Graph 3.8d 
Participant 10 Binocular Flippers Refractive State versus Time 
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Graph 3.8e 
Participant 10 Monocular Flippers Refractive State versus Time 
 
Graph 3.8f 
Participant 10 Small Font Refractive State versus Time 
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In summary, the preceding graphs (3.1a-f through 3.8a-f) reveal each participant’s 
accommodative lag by measuring their respective defocus during each testing duration.  A 
detailed analysis of these results in comparison to that of the expected results of a model eye may 
be found in the discussion section. 
The following graphs further isolate the pertinent refractive state data by focusing on the 
paraxial (central) refractive state data, as it most closely approximates the participant’s true point 
of focus and is irrespective of pupil size. The refractive state error was calculated at each data 
point over the time of the trial as the observed refractive state minus the target vergence (due to 
the accommodative stimulus).  The average refractive state error shows the average 
accommodative lag (positive error) or accommodative lead (negative error). An accommodative 
lag was seen in all testing conditions except those that involved the addition of a lens in the 
testing set-up: binocular and monocular flippers with flippers, and the close working distance 
condition.  When analyzed through the COAS aberrometer, the flipper used in the binocular and 
monocular flippers testing conditions resulted with an appearance of an increase in myopia, thus 
causing a data output of negative error values. This is seen consistently in each participants’ data. 
The finding that the close working distance condition resulted with negative error as well is more 
complex, and its analysis is presented in the discussion section.  
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Graph 4.1 
Participant 01 Refractive State Average Error Across Conditions 
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Graph 4.2 
Participant 03 Refractive State Average Error Across Conditions 
 
 As no video data exists to parse the with- and without-flippers data for the binocular 
flippers condition for participant 03, no graph was created for that condition. 
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Graph 4.3 
Participant 05 Refractive State Average Error Across Conditions 
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Graph 4.4 
Participant 06 Refractive State Average Error Across Conditions 
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Graph 4.5 
Participant 07 Refractive State Average Error Across Conditions 
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Graph 4.6 
Participant 08 Refractive State Average Error Across Conditions 
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Graph 4.7 
Participant 09 Refractive State Average Error Across Conditions 
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Graph 4.8 
Participant 10 Refractive State Average Error Across Conditions 
 
 The binocular flippers condition for participant 10 has no data collected without flippers.  
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To further espouse on the refractive state error over time, the following graphs combine 
all refractive state error data for all participants onto individual graphs, to provide an average 
slope. 
Graph 5.1 
Binocular Baseline Refractive State Error Across Participants 
 
Graph 5.2 
Monocular Baseline Refractive State Error Across Participants 
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Graph 5.3 
Small Font Refractive State Error Across Participants 
 
Graph 5.4 
Close Working Distance Refractive State Error Across Participants 
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Graph 5.5 
Binocular Flippers Refractive State Error Across Participants 
 
Graph 5.6 
Monocular Flippers Refractive State Error Across Participants 
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 The slopes found on the preceding graphs may then be analyzed via t-test to determine if 
the slopes are significantly different from zero. This is presented in Table 9. 
Table 9 
One-sample Two-tailed T-Test; Ho (that there is no difference between the population mean and 
zero) is rejected if p<0.05. 
Test 
Condition  Slope 
Binocular Baseline -0.00007  
Monocular Baseline -0.00009 
Small Font 0.0002 
Close Working 
Distance 0.0004 
Binocular Flippers 
(With Flipper) 0.0007 
Binocular Flippers 
(Without Flipper) 0.0004 
Monocular Flippers 
(With Flipper) 0.0008 
Monocular Flippers 
(Without Flipper) 0.0003 
  
Average 0.00033 
Standard Deviation 0.000321 
N 8 
p 0.0228 
 
As the p-value of 0.0228 is less than 0.05, the null hypothesis is rejected. The slopes are 
statistically different from zero. This shows that as participants get increasingly fatigued over the 
duration of the tests, their refractive state errors increase.  
To determine if participants who fatigue during the test scenarios have more variance 
overall, an ANOVA test was performed. The results may be seen in Graph 6.1 and Table 10.  
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Graph 6.1 
Total Variance Across Participants 
 
Table 10 
ANOVA Results 
Participant 
Binocular 
Baseline 
Monocular 
Baseline 
Small 
Font 
Close 
Working 
Distance 
Binocular 
Flippers 
Monocular 
Flippers 
01 0.046118 0.029219 0.016635 0.030535 0.233243 0.142742 
03 0.036234 0.03083 0.034282 0.192553 0.719349 0.20969 
05 0.045886 0.08229 0.054692 0.036331 0.449612 1.036992 
06 0.044086 0.055878 0.027807 0.145786 0.320503 0.549393 
07 0.023054 0.017564 0.021873 0.177879 0.085871 0.19411 
08 0.05189 0.065567 0.038393 0.15282 1.019165 0.794452 
09 0.05374 0.051529 0.057479 0.347914 0.361722 0.798228 
10 0.084463 0.028755 0.046469 0.097692 0.067525 0.252999 
n 8 8 8 8 8 8 
X 0.048 0.045 0.037 0.148 0.407 0.497 
s 0.018 0.022 0.015 0.101 0.323 0.345 
Xaverage 0.197      
       
Source df SS MS F P-value  
Treatments 5 1.66 0.332 8.4822 0  
Error 42 1.644 0.039    
Total 47 3.304     
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These ANOVA results show that p<0.05. Therefore, the null hypothesis that there is no 
difference between variances across conditions is rejected. This indicates that as participants 
become fatigued, they have an increase in the amount of refractive state error variance. 
Another analysis of variance allows determination of if variance increases over the course 
of a test scenario. This was performed by comparing the first 10 variance measures during each 
test scenario, with the last 10 variance measures. The results may be seen in Graph 6.6 and Table 
11. 
Graph 6.2 
Change in Variance Across Participants 
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Table 11 
ANOVA Results 
Participant 
Binocular 
Baseline 
Monocular 
Baseline 
Small 
Font 
Close 
Working 
Distance 
Binocular 
Flippers 
Monocular 
Flippers 
01 0.046118 0.029219 0.016635 0.030535 0.233243 0.142742 
03 0.036234 0.03083 0.034282 0.192553 0.719349 0.20969 
05 0.045886 0.08229 0.054692 0.036331 0.449612 1.036992 
06 0.044086 0.055878 0.027807 0.145786 0.320503 0.549393 
07 0.023054 0.017564 0.021873 0.177879 0.085871 0.19411 
08 0.05189 0.065567 0.038393 0.15282 1.019165 0.794452 
09 0.05374 0.051529 0.057479 0.347914 0.361722 0.798228 
10 0.084463 0.028755 0.046469 0.097692 0.067525 0.252999 
n 8 8 8 8 8 8 
X 0.048 0.045 0.037 0.148 0.407 0.497 
s 0.018 0.022 0.015 0.101 0.323 0.345 
Xave 0.197      
       
Source df SS MS F P-value  
Treatments 5 0.657 0.131 1.3495 0.2627  
Error 42 4.09     
Total 47 4.747     
 
These ANOVA results show that p>0.05. Therefore, the null hypothesis that here is there 
is no difference between change in variances across conditions is not rejected. This indicates that 
the variance does not steadily increase over the course of a test condition as the participant 
becomes fatigued. 
 These refractive state results, beginning with graph group 3 on page 49, are further 
explored in the discussion section.  
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 The next measure the COAS aberrometer performed was to measure the spherical 
aberration of the participants’ eye.  These findings are separated into graph groups 7, 8 and 9 on 
the following pages. 
Graph 7.1 
Participant 01 Average Spherical Aberration Graph 
 
Graph 7.2 
Participant 03 Average Spherical Aberration Graph 
 
As stated previously, the location of the flippers (in or out) for participant 3 is data 
missing at random.  
90 
 
Graph 7.3 
Participant 05 Average Spherical Aberration Graph 
 
Graph 7.4 
Participant 06 Average Spherical Aberration Graph 
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Graph 7.5 
Participant 07 Average Spherical Aberration Graph 
 
Graph 7.6 
Participant 08 Average Spherical Aberration Graph 
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Graph 7.7 
Participant 09 Average Spherical Aberration Graph 
 
Graph 7.8 
Participant 10 Average Spherical Aberration Graph 
 
As stated previously, no data was collected for the binocular flippers with flippers for 
participant 10. 
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 The preceding graphs show that in all testing scenarios and across all participants (except 
for two outliers, participants 09 and 10, in the close working distance condition only), the 
spherical aberration was found to be negative. This is a surprising finding, which is analyzed in 
depth in the discussion section.  
 The following graphs illustrate how spherical aberration varied over time for each 
participant. 
Graph 8.1  
Participant 01 Spherical Aberration versus Time  
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Graph 8.2  
Participant 03 Spherical Aberration versus Time  
 
Graph 8.3 
Participant 05 Spherical Aberration versus Time  
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Graph 8.4 
Participant 06 Spherical Aberration versus Time  
 
Graph 8.5 
Participant 07 Spherical Aberration versus Time  
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Graph 8.6 
Participant 08 Spherical Aberration versus Time  
 
Graph 8.7 
Participant 09 Spherical Aberration versus Time  
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Graph 8.8 
Participant 10 Spherical Aberration versus Time  
  
 The spherical aberration over time graphs show that the spherical aberration was 
generally stable (horizontal) for each participant in each condition. This is proven 
mathematically in table 12, below, after graphs 9.1 through 9.6 illustrate the spherical aberration 
across participants for each condition.  
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Graph 9.1 
Binocular Baseline Spherical Aberration Across Participants 
 
Graph 9.2 
Monocular Baseline Spherical Aberration Across Participants 
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Graph 9.3 
Small Font Spherical Aberration Across Participants 
 
Graph 9.4 
Close Working Distance Spherical Aberration Across Participants 
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Graph 9.5 
Binocular Flippers Spherical Aberration Across Participants 
 
Graph 9.6 
Monocular Flippers Spherical Aberration Across Participants 
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The slopes found on the preceding graphs may then be analyzed via t-test to determine if 
the slopes are significantly different from zero. This is presented in Table 12. 
Table 12 
One-sample Two-tailed T-Test; Ho (that there is no difference between the population mean and 
zero) is rejected if p<0.05. 
Test 
Condition  Slope 
Binocular Baseline 0.00002 
Monocular Baseline 0.00002 
Small Font 0.000006 
Close Working 
Distance -0.00006 
Binocular Flippers 
(With Flipper) 0.00003 
Binocular Flippers 
(Without Flipper) -0.00002 
Monocular Flippers 
(With Flipper) 0.00006 
Monocular Flippers 
(Without Flipper) 0.0001 
  
Average 1.95E-05 
Standard Deviation 4.82E-05 
N 8 
p 0.2905 
 
As the p-value of 0.2905 is greater than 0.05, the null hypothesis is not rejected. The 
slopes are not statistically different from zero. This shows that as participants get increasingly 
fatigued over the duration of the tests, their spherical aberrations remain stable.  
While pupil size can be eliminated as a variable in some case (e.g. the minRMS measure 
of refractive state varies with pupil size, but measures of central refractive state do not), spherical 
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aberration is always intrinsically linked to pupil size. The next graphs (10.1 through 10.8) 
represent the relationship between spherical aberration and pupil size. Pupil size will be further 
explored in graphs 11.1 through 11.8. 
Graph 10.1 
Participant 01 Spherical Aberration versus Pupil Size 
 
Graph 10.2 
Participant 03 Spherical Aberration versus Pupil Size 
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Graph 10.3 
Participant 05 Spherical Aberration versus Pupil Size 
 
Graph 10.4 
Participant 06 Spherical Aberration versus Pupil Size 
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Graph 10.5 
Participant 07 Spherical Aberration versus Pupil Size 
 
Graph 10.6 
Participant 08 Spherical Aberration versus Pupil Size 
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Graph 10.7 
Participant 09 Spherical Aberration versus Pupil Size 
 
Graph 10.8 
Participant 10 Spherical Aberration versus Pupil Size 
 
 The preceding graphs clearly indicate that as pupil size enlarges, the amount of spherical 
aberration also increases. The correlation between spherical aberration and pupil size is further 
explored in the discussion section. 
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 Pupil size individually may also be analyzed to determine how it was affected over the 
duration of the study. Graphs 11.1 through 11.8, graphs 12.1 through 12.6, and table 13 present 
this data.  
Graph 11.1  
Participant 01 Pupil Size versus Time 
 
Graph 11.2 
Participant 03 Pupil Size versus Time 
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Graph 11.3 
Participant 05 Pupil Size versus Time 
 
Graph 11.4 
Participant 06 Pupil Size versus Time 
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Graph 11.5 
Participant 07 Pupil Size versus Time 
 
Graph 11.6 
Participant 08 Pupil Size versus Time 
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Graph 11.7 
Participant 09 Pupil Size versus Time 
 
Graph 11.8 
Participant 10 Pupil Size versus Time 
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Graph 12.1  
Binocular Baseline Pupil Size Across Participants 
 
Graph 12.2 
Monocular Baseline Pupil Size Across Participants 
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Graph 12.3 
Small Font Pupil Size Across Participants 
 
Graph 12.4 
Close Working Distance Pupil Size Across Participants 
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Graph 12.5 
Binocular Flippers Pupil Size Across Participants 
 
Graph 12.6 
Monocular Flippers Pupil Size Across Participants 
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The slopes found on the preceding graphs may then be analyzed via t-test to determine if 
the slopes are significantly different from zero. This is presented in Table 13. 
Table 13 
One-sample Two-tailed T-Test; Ho (that there is no difference between the population mean and 
zero) is rejected if p<0.05. 
Test 
Condition  Slope 
Binocular Baseline 0.00002 
Monocular Baseline -0.0003 
Small Font -0.0003 
Close Working 
Distance 0.0004 
Binocular Flippers 
(With Flipper) 0.0015 
Binocular Flippers 
(Without Flipper) 0.0019 
Monocular Flippers 
(With Flipper) -0.0003 
Monocular Flippers 
(Without Flipper) -0.001 
  
Average 0.00024 
Standard Deviation 0.000987 
N 8 
p 0.514 
 
As the p-value of 0.514 is greater than 0.05, the null hypothesis is not rejected. The slopes are 
not statistically different from zero. This shows that as participants get increasingly fatigued over 
the duration of the tests, their pupil sizes remain stable. 
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Go-Pro Camera Video Recording Data 
 The video camera utilized in this study allowed for accurate measurement of two 
important variables: (1) Time to fatigue, and (2) fissure height of the participant’s eye during 
testing. 
 The duration of time to fatigue is presented in many of the graphs above, however, to 
more effectively view and compare between participants and conditions, the data may be 
separated into individual graphs.  
Graph 13.1 
Average Time to Fatigue Across Participants (by condition type, regardless of order performed) 
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Graph 13.2 
Average Time to Fatigue Across Participants (by order, regardless of condition type) 
 
 These graphs show that a condition that works to fatigue the subject appears to have a 
shorter duration of time. Further analysis of this data is relevant to determining if there is a 
statistical difference in time to fatigue based on the condition type or condition order. Tables 14 
and 15 present this analysis. 
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Table 14 
ANOVA Results; Ho (that there is no difference between the average time to fatigue based on 
condition type) is rejected if p<0.05. 
 
Binocular 
Flippers 
Monocular 
Flippers 
Close 
Working 
Distance 
Small 
Font Total 
N 8 8 8 8 32 
∑X 2456 3499 2639 4967 13561 
Mean 307 437.375 329.875 620.875 423.781 
∑X2 914086 1974407 1352109 3435967 7676569 
Std Dev 151.2302 251.8593 262.2891 224.2705 249.4944 
Source SS df MS 
Between 491895.8438 3 163965.281 
Within 1437775.625 28 51349.1295 
Error 443998.4063 21 21142.7813 
F= 7.75514 
p= .001133 
Significant @ p<0.05 
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Table 15 
ANOVA Results; Ho (that there is no difference between the average time to fatigue based on 
condition order) is rejected if p<0.05. 
 
Binocular 
Flippers 
Monocular 
Flippers 
Close 
Working 
Distance 
Small 
Font Total 
N 8 8 8 8 32 
∑X 3808 3395 2659 3699 13561 
Mean 476 424.375 332.375 462.375 423.781 
∑X2 2367746 1858753 1282231 2167839 7676569 
Std Dev 281.6122 244.365 238.5809 255.6543 249.4944 
Source SS df MS 
Between 100573.8 3 33524.61 
Within 1829098 28 65324.92 
Error 835320.4 21 39777.16 
F= 0.84281 
p= .485748 
Not Significant @ 
p<0.05 
 
 The result of significance by condition type and non-significance by condition order is an 
important distinction. This indicates that the order of condition type performance is irrelevant to 
the time to fatigue; it is the condition type that causes the participant to fatigue faster or slower. 
 Fissure height is the final measure collected for this study. Each participant’s right eye 
was measured by the COAS aberrometer and was therefore blocked to the view of the Go-Pro 
camera. The left eye, however, could be monitored for fissure height during each test duration. 
No data was collected on fissure height for the monocular conditions (baseline and flippers), as 
the left eye was occluded during those tests. Measurements were captured at the beginning of the 
test (at time equals 0 seconds), every 30 seconds thereafter, and at the conclusion of the test. 
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 Graphs 14.1 through 14.8 present each participant’s fissure height during each of these 
trials. 
Graph 14.1 
Participant 01 Fissure Height Across Conditions 
 
Graph 14.2 
Participant 03 Fissure Height Across Conditions 
 
 The binocular flippers and close working distance conditions fissure height 
measurements are data missing at random for participant 03. The video data files were not saved. 
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Graph 14.3 
Participant 05 Fissure Height Across Conditions 
 
Graph 14.4 
Participant 06 Fissure Height Across Conditions 
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Graph 14.5 
Participant 07 Fissure Height Across Conditions 
 
Graph 14.6 
Participant 08 Fissure Height Across Conditions 
 
 
121 
 
Graph 14.7 
Participant 09 Fissure Height Across Conditions 
 
Graph 14.8 
Participant 10 Fissure Height Across Conditions 
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 The shorter the task duration, the fewer measurements were taken. Nevertheless, in some, 
but not all instances, the participant’s fissure height decreased as they fatigued. This is consistent 
with the act of squinting. Table 16 presents the two-sample t-test results for each participant in 
each condition, indicating whether there is a statistical difference between the fissure height 
measurements captured in the first quarter of test time and last quarter of test time. 
Table 16 
Two-tailed paired T-Test for two dependent means; Ho (that any difference in first-and last-
quarter fissure height measures are due to chance) is rejected if p<0.0125 
(Bonferroni correction was utilized to determine the p-value: alpha of 0.05 divided by 4 
induction testing categories equals new p-value of 0.0125. The Blue data in the following graph 
represents non-significance at p>0.0125; Red represents significance at p<0.0125.) 
Participant Binocular Baseline Small Font Close Working Distance Binocular Flippers 
01 0.008 0.006 0.121 0.25 
03 0.004 <0.001 No data No data 
05 0.114 0.014 0.07 0.132 
06 0.002 0.494 0.842 0.728 
07 0.142 0.226 0.339 0.185 
08 0.108 0.037 0.049 0.017 
09 0.715 0.917 0.315 <0.001 
10 0.057 0.023 0.682 0.863 
 
 As may be seen in the graph above, only a few instances, and primarily in the binocular 
baseline category (where every participant was required to complete 15 minutes of testing) is the 
test result indicative of significant squint. 
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 Finally, an exploration of any relationship between refractive state error and fissure 
height was performed. As these two measurements are unrelated except for their occurrence at a 
given point in time, a correlation analysis was performed.  Table 17 reports R, the correlation 
coefficient found for each instance. Table 18 reports R-squared. Again, due to the ability of the 
video to capture only images of the participant’s left eye, no monocular conditions are reported 
here. 
Table 17 
Correlation Coefficient between Refractive State Error and Fissure Height (red represents a 
correlation coefficient of at least +/- 0.5, indicating a strong correlation) 
Participant Binocular Baseline Small Font Close Working Distance Binocular Flippers 
01 0.565793 -0.30433 -0.40252 0.564211 
03 -0.00205 0.651438 No Data No Data 
05 0.256379 -0.2347 -0.46362 -0.78449 
06 0.418876 -0.52531 -0.93302 -0.41294 
07 0.181212 0.194816 -0.80297 -0.81295 
08 -0.46619 -0.28203 -0.52099 0.273257 
09 0.23592 -0.04133 -0.76495 -0.98161 
10 0.066247 -0.09281 -0.05747 -0.34999 
 
 Negative correlation indicates that as refractive state error increases, fissure height 
decreases. Positive correlation indicates that as refractive state error increases, fissure height also 
increases.  
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Table 18 
Coefficient of Determination (R2) between Refractive State Error and Fissure Height (red 
represents R2 values of over 50%) 
Participant Binocular Baseline Small Font Close Working Distance Binocular Flippers 
01 32.01215 9.261738 16.20188 31.83339 
03 0.000421 42.43713 No Data No Data 
05 6.573015 5.508215 21.49468 61.54216 
06 17.54569 27.59472 87.05287 17.05183 
07 3.283771 3.795347 64.4756 66.08927 
08 21.73309 7.953998 27.14304 7.466926 
09 5.565836 0.17078 58.51429 96.3552 
10 0.438862 0.861296 0.330329 12.24963 
 
This table shows the percentages at which the variance of refractive state error is related 
to the variance of fissure height. Those with strong R2 values (highlighted in red) indicate that 
their respective fissure heights and refractive state errors are closely linked.  
The strongest coefficient values indicate a negative correlation between refractive state 
error and fissure height. Knowing from previously reported data (see Table 9) that as participants 
fatigued, their refractive state errors increased; therefore, with increasing fatigue and refractive 
state error, fissure height decreases.  This is indicative of squinting. 
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Discussion 
The two-visit organization of this study ensured that the participant selection could be 
isolated to groups with or without specific parameters. Especially important, due to the small 
number of participants in this pilot study, the participant selection required isolation of 
individuals with no pre-existing medical, binocular vision, dry eye or refractive problems which 
could confound the data collected. The screening-visit proved successful in facilitating the rapid 
disqualification of participants who did not meet the inclusion/exclusion criteria set for this 
study. Ultimately, two prospective participants were disqualified from completing the study 
based on the results of the screening-visit. Both participants were found to have pre-existing dry 
eye symptoms, as indicated by a CLDEQ-8 score of over 12.85,86 The remaining eight 
participants were an adequate number to complete the gathering of pilot data.   
While no participants were disqualified due to refractive errors outside of the range 
presented in the inclusion criteria, a careful refraction with and without cycloplegia was 
performed at the screening-visit.  This purpose was to ensure the contact lenses selected for the 
study-visit would neither help (if under-minused) or hinder (if over-minused) the participant’s 
performance in the testing scenarios.  Tropicamide 1% was selected for use as the cycloplegic 
agent in this study rather than cyclopentolate 1%, as studies have shown minimal to no 
difference in cycloplegic refractions performed with both eyedrops, and tropicamide 1% has a 
                                                          
85 Chalmers RL, Keay L, Hickso-Curran SB, Gleason WJ. Cutoff score and responsiveness of the 8-item Contact 
Lens Dry Eye Questionnaire (CLDEQ-8) in a Large daily disposable contact lens registry. Contact Lens and 
Anterior Eye. 2006 Oct. 39(5): 342-352. 
86 Chalmers RL, Begley CG, Moody K, Hickson-Curran SB. Contact Lens Dry Eye Questionnaire-8 (CLDEQ-8) 
and Opinion of Contact Lens Performance. Optometry and Vision Science. 2012 Oct. 89(10): 1435-1442. 
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faster onset of maximum cycloplegic effect (at 30 minutes).87,88 The study-visit was performed at 
least 24 hours after the screening-visit to ensure the Tropicamide 1% dilation eyedrop used to 
gather accurate refractive testing data was no longer active.89  Biofinity sphere contact lenses 
(CooperVision, Fairport, NY) fit for each participant’s optimal distance refraction were selected 
for use in this pilot study. This specific lens was selected for two reasons: (1) Prior studies 
related to asthenopia performed in the Clinical Optics Research Laboratory at Indiana University 
utilized the Biofinity sphere lens, as it is designed with CooperVision’s proprietary Aberration 
Neutralizing System™, which are aspheric optics designed to “minimize spherical aberrations 
inherent in both the lens and eye.”90 As the human eye contains positive spherical aberration, the 
induction of controlled levels of negative spherical aberration in the manufacturing of contact 
lenses has been found to improve visual acuity.91,92 (2) It was known that the Biofinity Energys 
contact lens was nearing its product launch.  Biofinity contact lenses (with the same material, 
base curvature, diameter, and wear regimen as Energys) would provide an excellent control lens 
in a future study. 
The purpose of the study-visit design was to allow statistical analysis which separated 
known sources of variation from random error. By using the specialized randomization technique 
                                                          
87 Lin LKL, Shih YF, Hsiao CH, Su TC, Chen CJ, Hung PT. The Cycloplegic Effects of Cyclopentolate and 
Tropicamide on Myopic Children. Journal of Ocular Pharmacology and Therapeutics. 2009 Jan. 14(4): 332-335.  
88 Hofmeister EM, Kaupp SE, Schallhorn SC. Comparison of tropicamide and cyclopentolate for cycloplegic 
refractions in myopic adult refractive surgery patients. Journal of Cataract & Refractive Surgery. 2005 Apr. 31(4): 
694-700. 
89 Mydriacyl Product Information. Available at: 
http://www.medsafe.govt.nz/profs/datasheet/m/Mydriacyleyedrop.pdf. Accessed: September 2, 2017.  
90 Biofinity: Improving the Way People See, Whatever Their Visual Needs. October 10, 2017. Available At: 
https://coopervision.com/practitioner/our-insights/product-spotlight/biofinity-improving-way-people-see-whatever-
their-visual-needs. Accessed: October 27, 2019. 
91 Rae SM, Allen PM, Radhakrishnan H, Theagarayan B, Price HC, Sailaganathan A, Calver RI, O’Leary DJ. 
Increasing negative spherical aberration with soft contact lenses improves high and low contrast visual acuity in 
young adults. Ophthalmic & Physiological Optics. 2009 Oct. 29: 593-601. 
92 Wagner S, Conrad F, Bakaraju RC, Fedtke C, Ehrmann L, Holden BA. Power profiles of single vision and 
multifocal soft contact lenses. Contact Lens & Anterior Eye. 2015 Feb. 38(1):2-14. 
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of the Latin square, the number of participants required to complete the experiment were kept to 
a minimum, while the analysis accounted for variance between subject and order.  The ANOVA 
table for a typical Latin square analysis may be seen in Table 19:93 
Table 19 
ANOVA Table for Latin Square 
Source df SS MS F 
Rows r - 1 SSR SSR/(r-1) MSR/MSE 
Columns r - 1 SSC SSC/(r-1) MSC/MSE 
Treatments r - 1 SST SST/(r-1) MST/MSE 
Error (r-1)(r-2) SSE SSE/((r-1)(r-2))  
Total r2-1 TSS     
 
The benefit to this experiment of utilizing the Latin square statistical design was that the 
sum of squares of the rows and columns are accounted for separately, and not incorporated into 
the error term. This reduced the expected size of the MSE variable (treatment/error degrees of 
freedom), thus enlarging the MST/MSE total value, increasing the likelihood of reaching 
significance and finding that Hi is true.  Additionally, by having increased the number of 
participants to 8 from the requisite 4, the ANOVA table changed slightly to further decrease the 
error variable (MSE). The ANOVA table for the repeated Latin square was presented as Table 4, 
where the only change from the traditional Latin square design may be seen by the multiplication 
by 2 of the degrees of freedom in the error row: 2(r-1)(r-2).  As considerable variability was 
expected between participants, the repeated Latin square design was utilized, to increase the 
degrees of freedom for experimental error.94  This may be visualized in Figure 4, where rows 
                                                          
93 Dubcovsky, J. Double Block Designs: Latin Squares. 
94 Ibid. 
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(D), columns (T) and the repeated Latin square (S) show how the additional subjects (added to 
reduce experimental error) are randomized in repetition, sharing the same rows and columns.  
The randomization scheme utilized in this experiment (Table 3) shows this same design. 
Figure 4 
Repeated Latin Square 
 
As with any Latin square designed experiment, the test is not particularly sensitive to 
handling significant interactions between the variables presented in the rows and columns, as 
interactions inflate the MSE (error term) resulting in decreased likelihood of reaching statistical 
significance.95  Having made the assumption of no interaction between these variables, this 
analysis should result with enough power to come to a conclusion. 
The study-visit presented four testing scenarios for future research: to explore which 
asthenopia induction testing method as analyzed by measurement of defocus, pupil size, and 
spherical aberration by the COAS aberrometer would provide the easiest repeatability and best 
comparison to baseline data, to allow for objective measurement if asthenopia were relieved via 
use of an optical device.  More specifically, time at task and refractive state error and variability 
(measured via accommodation) were the most important factors to consider, as it would be 
expected that a successful task would have a higher variability, shorter duration of time, and 
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potentially larger refractive state errors or errors that would increase over the test duration. 
Special considerations needed to be made to replicate the induction techniques performed in 
previous literature, while allowing for effective use of the COAS aberrometer. 
The -3.00 DS binocular flipper was selected to mimic traditional accommodative facility 
testing in an optometric setting, and a -3.00 DS trial lens alone was selected for the monocular 
flipper condition.96,97 The study method of flipping between a minus lens and no lens was 
designed to eliminate the possibility of a COAS reading in between the induced stress and 
relaxed condition (e.g. if the participant was half-way through flipping a traditional +/-2.00 DS 
flipper, a reading would be considered invalid, as too many variables exist in that moment to 
warrant investigation of that data point). A -3.00 DS lens was selected for the condition as a 
stimulus to accommodation, to be contrasted with “neutral,” that is, no lens. Though the purpose 
of both flipper conditions was to fatigue a participant’s accommodative facility, they were tested 
separately in this experiment just as they are tested separately in a clinical setting. The binocular 
flipper purpose was to test the ability to stimulate and relax accommodation while maintaining 
convergence, while the monocular flipper tests the accommodative system alone. 
The small font condition replicated the 5-point font at 60 cm working distance that was 
presented as the standard in previous literature.98 The replication was accomplished by 
mathematically matching the font size of the Mahjong tile image to 1 mm height (for the 
mathematical conversion, see Appendix 5). 
                                                          
96 Allison C. Eyedentify Your Patient’s Efficiency Problems. Review of Optometry. June 15, 2005. Available at: 
https://www.reviewofoptometry.com/article/eyedentify-your-patients-efficiency-problems. Accessed on: September 
4, 2017. 
97 Chen A, Borsting E, Lao M, Yang J. Accommodative Facility Measured by +/-2.00 Flipper and Dioptrically 
Equivalent Target Distances. Abstract. Presented at: Annual Meeting of the American Academy of Optometry; 
October 2010; San Francisco, CA, USA. 
98 Gowrisankaran S, et al. Eyelid Squint Response to Asthenopia-Inducing Conditions. 
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The close working distance condition brought the stimulus screen to a 20 cm working 
distance while a +5.00 DS pair of spectacles was utilized rather than a trial lens.  The goal was to 
closely match the participant’s interpupillary distance to avoid inducing any prismatic effects 
(which would have invalidated the data by inducing variable vergence strain that would differ 
between participants).  This set up differed slightly from previous studies, which utilized a 16.7 
cm working distance and +6.00 DS spectacles.99,100 The 20 cm working distance utilized in this 
experiment was required due to the presence of the COAS, as binocularity was lost with a closer 
working distance as the instrument blocked view of part of the stimulus screen. 
As with any game used as a stimulus item, as the study progressed and more puzzles 
were completed, it was expected that the participant’s skill at solving the game puzzles would 
improve.101 Therefore, for this study, it was deemed necessary to find a way to minimize the 
effect participant game skill and adaptation would have on the results. After consideration, it was 
determined that a randomized matching game such as Mahjong would provide less of this 
effect.102   
The Go-Pro Hero 4 silver edition digital camera required special considerations to its 
efficacy as a tool in capturing data on fissure height. Fortunately, since the data being compared 
is of ratios between measurements, the pixel length change due to the addition of lenses (for 
instance, the -3.00 DS lenses in the flipper task, or +5.00 DS lenses in the close working distance 
task) is irrelevant. For example, measured in Photoshop, 77 pixels are counted in diameter of an 
                                                          
99 Ibid. 
100 Sheedy JE, et al. Is All Asthenopia the Same? 
101 Eversheim U and Bock O. Evidence for Processing Stages in Skill Acquisition: A Dual-Task Study. Learning & 
Memory. 2001 Jul. 8(4): 183-189. 
102 Järvelä S, Ekman I, Kivikangas JM, Ravaja N. A Practical Guide to Using Digital Games as an Experiment 
Stimulus. Transactions of the Digital Games Research Association. 2014 Mar. 1(2). Available at: 
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image of a 1 cm distance on a PD stick at the 22 cm working distance. If a +2.00 DS lens is 
placed directly in front of the PD stick, the pixels increase to 81 per 1 cm distance of the imaged 
PD stick. A -2.00 DS lens results with 75 pixels. A +6.00 DS lens results with 83 pixels. Put 
simply, a percentage change is required for the analysis of images across testing scenarios, as the 
number of pixels, or lengths, is not directly comparable without factoring in the shift due to the 
lenses used in each testing scenario.  While the testing scenarios presented in this study would 
not all lend themselves to squint, this analysis could be made using the recorded data from the 
GoPro camera, to confirm the repeatability of past squint study findings.  Following the 
precedent set by Gowrisankaran’s 2007 study on “Eyelid Squint Response to Asthenopia-
Inducing Conditions,” high quality image capture collected of the participant’s left eye during 
the testing scenarios could provide information on fissure height (see Graphs 14.1-14.8). 
Gowrisankaran’s results focused on contracture of the orbicularis oculi, which was found to a 
small degree in all asthenopia-inducing conditions (including those repeated in this study) but 
statistically significant squint was only seen in instances where squinting would truly improve 
visual clarity via the pinhole effect.103 Comparatively, in this study few instances of statistically 
significant squint were found (see Tables 16, 17, and 18). However, in the cases where squint 
was seen, it correlates with the expected pattern that with increasing fatigue and refractive state 
error, squinting too is found to increase. 
A fifteen-minute wash-out period of rest was in place after each asthenopia induction 
testing scenario, to allow for accommodative and convergence fatigue to recover. This time was 
lengthened from what has been previously performed in the literature, where a brief five-minute 
                                                          
103 Gowrisankaran S, et al. Eyelid Squint Response to Asthenopia-Inducing Conditions. 
132 
 
wash-out period was determined to be “sufficient based on symptom scores”.104,105 The 
lengthened rest period was utilized for this procedure to ensure adequate recovery regardless of 
the severity level of asthenopia achieved in the testing phase. Success of this fifteen-minute 
wash-out period is further expressed in the time to fatigue analysis (see Tables 14 and 15) which 
show that time to fatigue was impacted solely on the condition type, and that the order of 
conditions performed had no effect. Interestingly, the symptom severity scale results did show a 
replicable pattern consistent with adaptation.  The results (which may be seen in graphs 2.1 
through 2.8 in the Results section) show some negative values in the change in severity scale 
scores.  This indicates that after experiencing discomfort during a task, when the uncomfortable 
stimulus was removed (that is, the task completed) the participant subjectively felt “better” than 
they had before the testing was initiated. An example of this phenomenon experienced in daily 
life is of simple light adaptation: if one exits a dimly lit room into bright sunshine and then 
returns to the room, it will appear darker than it initially had, due to light adaptation.  
Non-invasive tear break up time (NITBUT) measurements were performed before and 
after each testing scenario. The statistical analysis (presented in tables 5.1, 5.2, 6.1 and 6.2 in the 
Results section) all show p-values of greater than 0.05. This conclusively agrees with the null 
hypothesis that any change in NITBUT is due to chance. This replicates previous dry eye studies 
that reveal no correlation between the signs and symptoms of dry eye.106 This proves that dry eye 
may be excluded as a factor in the asthenopia induced in this experiment, allowing the COAS 
data to be reviewed on its own. 
                                                          
104 Ibid. 
105 Gowrisankaran S, et al. Eyelid Squint Response to Asthenopia-Inducing Conditions. 
106 Bartett HD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and syptoms of dry eye disease: a 
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The study-visit was designed to explore the four asthenopia induction methods, described 
above, to determine which would be the most promising scheme for future investigation. This 
was performed by analyzing the data subsets of refractive state, spherical aberration and pupil 
size data as captured by the COAS Aberrometer for each participant in each of the four 
asthenopia induction methods.  
As a control, baseline data in all three subsets was first captured for each task condition 
to be compared to.  This data was collected by having each participant perform the task stimulus 
for a full 15-minute session and was performed in both binocular and monocular conditions. 
Distance pre- and post-test data was collected with a focal point at optical infinity, to confirm (1) 
that the participant’s accommodative system was properly functioning and (2) that the COAS 
was detecting defocus measurements in accordance with the task set up alone. See Appendix 6 
for graphs which concur with the expectations highlighted in the previous sentence. Additionally, 
a short monocular and binocular post-test data set was collected for comparison with the 
monocular and binocular baseline data, to ensure that the proposed control data could be used as 
such. These post-test graphs may be viewed in Appendix 7. 
Analysis of refractive state over time showed similar results across participants (see 
graphs 3.1a-f through 3.8a-f in the Results section).  
Defocus data collected centrally (paraxial accommodation) and minRMS are only exactly 
aligned when negative spherical aberration is at zero, which may only occur when pupils are 
very small. A primary example of this finding is in the close working distance condition. The 
greater the difference between the paraxial and minRMS readings, the larger the amount of 
negative spherical aberration.  In contrast to the close working distance condition, a separation of 
the paraxial and minRMS data is well highlighted in the monocular baseline condition.  
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Measurements of paraxial accommodation are very accurate as to the participant’s true 
point of focus. While most often it was found to be directed exactly at the target stimulus 
location, some tasks resulted with an offset. The close working condition universally resulted 
with a slight over-accommodation.  The increased convergence demand in the close working 
distance condition may have increased the accommodative response over what was strictly 
necessary; when the convergence demand was eliminated in the monocular conditions, 
accommodation was always found to be less than the target stimulus demand. Interestingly, the 
distance baseline and post-test data revealed a similar trend of a subtle over-accommodation (see 
Appendix 6. For optimal subjective distance viewing, myopic individuals often request slightly 
higher amounts of minus-lens prescriptions than is strictly necessary based on their objective 
optical requirement. As every effort was made in this study to fully and accurately correct the 
participants’ refractive errors, subjective under-correction may be expected when viewing a 
distance target without effects of a cycloplegic agent. Under all other testing conditions (tasks, 
baseline, and post-test data) the paraxial accommodative data revealed either a true focus on the 
target stimulus, or a small under-accommodation. This is consistent with a clinically normal lag 
of accommodation in the pre-presbyopic population, which is considered +0.50 to +0.75 D of 
lag.107 
The flippers conditions revealed a more complex analysis of results. Over time, an 
increase in accommodative relaxation was seen with the insertion of the flippers, with an 
increased variability of results but generally low gain of the accommodative response. While this 
may be expected in patients with a high CA/C ratio (dominant vergence control of 
accommodation), the screening protocol confirmed that all participants had normal 
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accommodative and vergence systems.  Additionally, in some instances the participants’ 
accommodative response moved in the incorrect direction (e.g. increasing accommodation when 
the flippers were removed, and accommodation should have relaxed). A clear example of his is 
may be seen in the circled portion of Graph 15. 
Graph 15 
Copy of Graph 3.4d with Illustration of Incorrect Accommodative Response 
 
Indeed, in the monocular flippers condition (Graphs 3.1-3.8e), when the convergence 
cues were removed, on most trials the accommodation is not relaxed at all (see paraxial data 
close to the 2.50 D stimulus). A clear example of his is seen in Graph 16.  
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Graph 16 
Copy of Graph 3.2e with Illustration of Accommodative Response close to 2.50 D 
 
 
What seems most intriguing about the results of both binocular and monocular flipper 
conditions is that a simple accommodation (+) / relaxation (-) response was not found.  In a 
model eye, the accommodative system would compensate for the full power of the lens flipper, 
and measurement of defocus would not change. After fatiguing, the time to achieve clarity 
(regardless of amount of lag) will increase in duration, and eventually will not be achieved (see 
Figure 5).  
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Figure 5 
 Schematic of the Expected Pattern of Ocular Fatigue in a Flipper Task 
 
 
 
 
 
Figure 6 
Schematic of the Expected Pattern of Ocular Fatigue in a Close Working Distance or Small Font 
Task 
 
In comparison to the binocular and monocular flipper conditions, the stimulus in the 
small font and close working distance tasks kept a stable accommodative stimulus in place. 
Rather than the accommodation and relaxation changes expected with the lens flipper condition, 
a slow increase in defocus would be expected as the participant’s accommodative and 
convergence system fatigued. While a subtle trend toward increased accommodative lag may be 
seen overall across the tasks, it was not a pronounced drop off-of accommodative ability that 
immediately preceded the stopping of the task due to “100% barely tolerable eyestrain” being 
achieved.  
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Refractive state error (determined as the actual refractive state error found by the COAS 
aberrometer minus the expected refractive state error indicated by the accommodative stimulus 
presented in the test) was consistent across participants, showing that as participants became 
increasingly fatigued over the duration of the tests, their refractive state errors increased. Further 
analysis of these measures indicates that with fatigue, the total refractive state error variance 
across conditions also increases. However, comparing variances within each condition revealed 
that variance does not increase over the duration of each test. Nevertheless, the proof that this 
increase in variability is consistent across participants over the duration of each test concurs with 
one of the primary outcome expectations. 
Before analyzing any of the spherical aberration results, it should be highlighted that the 
finding of negative spherical aberration across participants in all conditions was a surprising 
result, as the human eye naturally has positive spherical aberration.  There are two likely reasons 
for this finding: (1) While spherical aberration is typically positive for unaccommodated eyes,108 
as eyes accommodate, spherical aberration becomes increasingly negative.109 (2) As described 
earlier in this section in the paragraph describing the selection of the Biofinity sphere lens for 
this study, past studies utilizing Shack-Hartmann wavefront aberrometry (first presented by 
Kollbaum et al, 2008)110 have identified that many soft contact lenses, including the Biofinity 
sphere, have inherent negative spherical aberration.111 The negative spherical aberration present 
in the Biofinity sphere varies with lens power, with increasing amounts of negative spherical 
                                                          
108 Thibos LN, Hong X, Bradley A, Cheng X. Statistical variation of aberration structure and image quality in a 
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139 
 
aberration with increasingly minus refractive power.112 Table 20 presents the refractive 
correction needed for the eye measured by the COAS Aberrometer for each participant.  
Table 20  
Biofinity Sphere Right Eye Contact Lens Powers Utilized 
Participant Right eye (D) 
01 -2.50 
03 -4.25 
05 -1.25 
06 -2.00 
07 -2.25 
08 -2.75 
09 -4.25 
10 -1.50 
 
Based on the lenses used, one might infer that participants 03 and 09 would have a 
greater amount of negative spherical aberration than the other participants. In a comparison of 
means between participants 03 and 09, their p-value is 0.2491, which is >0.05, indicating that 
there is no statistical difference in the average spherical aberrations between the participants with 
the highest myopic refractive error. Table 21 presents this same comparison of means across the 
other participants. 
 
 
                                                          
112 Ibid. 
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Table 21 
Comparison of mean spherical aberration values between participants 03 and 09 and the other 
test subjects; Ho (that any difference in average spherical aberration is due to chance) is 
rejected if p<0.05) (Blue represents non-significance at p>0.05; Red represents significance at 
p<0.05.) 
Participant P-value for comparison to  
Participant 03 
P-value for comparison to  
Participant 09 
01 0.0014 0.541 
05 0.3783 0.4001 
06 0.0012 0.0074 
07 0.5753 0.3049 
08 0.0198 0.7999 
10 0.6557 0.1501 
 
 With the knowledge that no statistical difference exists between the average spherical 
aberration of participants 03 and 09, it is only participant 06 that results with a true difference in 
mean spherical aberration. While participant 06 has a refractive error of less than half of the 
highest prescription, it is not the lowest refractive error present in this study.  Those belong to 
participants 05 and 10, both of whom show no statistical difference in average spherical 
aberration with the highest refractive errors.  These results indicate that the amount of negative 
spherical aberration induced by the Biofinity contact lens may be considered equal across 
participants for the purposes of this study. Ultimately, while it is possible that the level of 
negative spherical aberration present in the Biofinity Sphere contact lens could have subtly 
impacted each participant’s results, this would vary based on the individual’s naturally occurring 
spherical aberration which was not measured in this study. 
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Knowing that negative spherical aberration is now expected for all participants, variations 
in the amount of spherical aberration may be considered.  In the human eye, variations in the 
amount of spherical aberration are found in response to two factors: one, changing pupil size, 
and two, during accommodation due to flexure of the crystalline lens.   
An increase in pupil size correlates with an increase in spherical aberration. This is 
corroborated by all spherical aberration data analyzed: average spherical aberration (Graphs 7.1-
7.8), spherical aberration versus time (Graphs 8.1-8.8 and 9.1-9.6) , and spherical aberration 
versus pupil size (Graphs 10.1-10.8).  
The most pronounced example in the average spherical aberration data is the close 
working distance condition, which caused a triad of involuntary ocular responses in all 
participants: convergence, accommodation, and miosis.  The miosis caused lower levels of 
negative spherical aberration to be found in the close working distance condition than all other 
tasks, across all subjects (see graphs 7.1-7.8 in results section).  
Graphs of spherical aberration versus time and pupil size versus time (see plots 8.1-8.8 
and 11.1-11.8, respectively) showed largely static (horizontal) trends for each condition. This 
was proven in Tables 12 and 13, which show that across conditions even as participants became 
fatigued, their spherical aberration and pupil size measures remained stable.  These results 
express that the greatest factor affecting spherical aberration was pupil size.  
Finally, as spherical aberration is a known wavefront characteristic of the eye that varies 
with the fourth power of the pupil radius, a two-fold change in pupil size results with at 16-fold 
change in spherical aberration. This correlation can be clearly seen (Graphs 10.1-10.8) showing 
an increase in spherical aberration with an increase in pupil size. 
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Variability of spherical aberration with accommodation is more complex. Studies have 
shown that primary spherical aberration decreases during accommodation.113 Additionally, as 
pupil size and accommodation are inextricably linked, in can be expected that with increased 
accommodative demand (e.g. with -3.00 DS flippers in the binocular and monocular flippers 
condition, which resulted in a +3.00 DS accommodative demand to the eye) that negative 
spherical aberration would decrease during flipper use due to the miosis inherent with the 
accommodation. However, a decrease in negative spherical aberration with increased 
accommodative demand was not always found to be the case in the flippers conditions (see 
Graphs 7.1-7.8). While this seems opposite to the standard behavior expected, it is likely due to 
pupil dilation – if the negative spherical aberration level did not change but the pupil size 
increased as the accommodative system relaxed, an increase in negative spherical aberration 
would be found. However, the expected correlation between increased accommodative demand 
and decreased negative spherical aberration was seen consistently when the accommodative 
demand was static, in all conditions aside from the flippers. 
While a great deal of analysis can be gleaned from the results of this pilot study, there 
existed limitations in the study design that affected the data collection of each participant in each 
induction-testing modality to some degree.  Data corruption during testing occurred via both 
involuntary and voluntary actions of the participant in the project set-up.  
Involuntary data corruption occurred when the COAS image capture did not provide 
usable data for analysis. This occurred if the participant’s eye moved off-center (resulting in the 
wavefront image moved partially off screen, or Purkinje images which corrupt the center-most 
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part of the image), if the participant were blinking at the time of image capture (resulting in no 
data), or if the method resulted in a lack of image capture (e.g. if the edge of lens flipper 
obscured the wavefront image).   
Figure 7 
Examples of COAS Wavefront Images 
 
   Good quality image capture    Poor quality image capture 
With the COAS wavefront image capture occurring every 2 seconds throughout the 
duration of the tasks, though many data points were collected for each participant, they were not 
necessarily measured at the same time during the task.  This discrepancy existed between 
participants as well as between tasks performed by the same participant.  Additional variability 
of data capture time occurred because the COAS system was run through Windows XP, and had 
a capability of just 43 image captures before it shut down. Mathematically, this converts to a shut 
down every 1 minute 26 seconds, and was therefore expected to occur 10 times per 15 minute 
testing condition. When this occurred in this experiment, the investigator would as quickly as 
possible restart the “free running” alignment screen, confirm and/or adjust the patient’s 
positioning to ensure good quality of wavefront images, and begin acquiring the next set of 43 
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data points. This process took at least 10 seconds, longer if it were discovered on the “free 
running” screen that the image capture needed adjusting (e.g. if Purkinje images were visible or 
the participant was not aligned properly). 
Consider the binocular baseline task, performed for a total of 15 minutes across all 
participants. Theoretically, 450 total image captures were to be collected, if the COAS system 
were running continuously. Highlighted in Table 22, the variability of data volume collected is 
clear.  
Table 22 
Binocular Baseline Data Captured (with highlights indicating data variability) 
     
       Causes of corrupted 
images 
Participant 
Number 
Total 
Images 
captured 
Total 
usable 
images 
Total 
images 
missing 
Total 
corrupted 
images Blinks  
Poor 
image 
capture  
Purkinje 
distortion  
01 387 325 63 62 17 13 32 
03 423 393 27 30 19 11 0 
05 374 254 76 120 14 100 6 
06 412 298 38 114 5 6 103 
07 383 299 67 84 36 26 22 
08 389 310 61 79 28 37 14 
09 371 223 79 148 12 81 55 
10 371 328 79 43 18 25 0 
 
In theory, more image capture would be indicative of less fatigue. This could have been 
an additional measure to compare with the time to fatigue (in seconds) results. However, with the 
large amount of error in data capture, the image capture variable does not represent a viable 
analysis of fatigue occurrence. 
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Similar variability was seen within every task presented to each participant.  To limit the 
variability in data volume and times of data collection between participants and between tasks 
performed by the same participant, future experiments utilizing the COAS in real-time image 
capture would benefit from a shorter test duration.  Limiting wavefront image captures to the 
maximum capability of the COAS system would prevent variability of time during testing that 
the data points were obtained across participants and tasks. Another benefit to eliminating the 
need to restart the data collection in the middle of a task, is the minimization of total data points 
collected. Fewer data points could be exported and analyzed quickly for corruption (due to the 
blinks, poor image capture, or Purkinje images), allowing the investigator to repeat the test, if 
needed, to improve the data quality. 
The second type of data corruption seen in this pilot study was voluntary data corruption, 
which occurred when participants did not follow the instructions given by the investigator.  
Examples of this were not malicious in nature – none of the participants were actively 
disobeying instructions. Rather, errors arose from poor understanding of the task or by nature of 
a participant’s eye to behave differently than expected.  This type of corruption arose in three of 
the four testing scenarios: suppression of an eye during the close working distance condition, and 
variations of time to flipper change in the monocular and binocular flipper conditions. 
Suppression of an eye during the close working distance condition resulted with 
inaccurate data collection.  This occurred most obviously during Participant 08’s fourth testing 
scenario, which allowed completion of the full 15 minutes (900 seconds) of data collection, and 
an end-rating of just 50% “barely tolerable eyestrain.” This data is presented in Table 23. 
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Table 23 
Close Working Distance Time to Fatigue and Subjective Eyestrain Results 
Participant Time to Fatigue (seconds) Percent “Barely Tolerable  
Eyestrain” Achieved 
1 396 100 
3 262 100 
5 432 100 
6 82 100 
7 263 100 
8 900 50 
9 72 100 
10 160 100 
 
Participant 08’s 900 seconds of test duration may be contrasted with the next longest time 
to reach 100% “barely tolerable eyestrain” (Participant 05) at 432 seconds (7 minutes 15 
seconds). Excluding Participant 08, the average time to the stopping point of “100% barely 
tolerable eyestrain” for the close working distance scenario was 254 seconds (4 minutes 14 
seconds), clearly indicating that Participant 08’s results were an outlier.  
Video recording of the binocular and monocular flipper testing scenarios showed how 
each participant’s time to change the binocular and monocular flippers varied.  The instructions 
for the flipper conditions were to clear the stimulus screen and make a Mahjong tile match, 
before flipping the lens.  For example, in both the monocular and binocular flipper conditions, 
Participant 09 had durations between flips between of as little as 2 seconds both at the beginning 
and end of the testing session. Participant 05 had similar speed with the binocular flippers. The 
only possibility of flipping a lens this quickly would be if the participant had memorized more 
than one tile match in the game, likely when the vision was clearest.  This would allow the 
participant to make matches even if they had not fully cleared the vision of the game board.  
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Memorizing tile location and planning future matches would allow for faster flipping, and more 
time spent in the more visually comfortable flipper position.  This behavior is in contrast to 
Participant 06, who, for example, at 229 seconds (the 3 minutes 49 second mark) of the binocular 
flipper testing, required 18 seconds to remove the -3.00 binocular flipper, and then required a full 
69 seconds of time without the flipper in place to focus enough to make a match before replacing 
the flipper at 316 seconds (the 5 minutes 16 seconds mark).  Interestingly, speed between flips 
seemed to have little consequence on the time until stopping due to “100% barely tolerable 
eyestrain achieved.” Participant 09 (fast flipper) stopped the trial at 137 seconds (2 minutes 17 
seconds), Participant 05 (fast flipper) at 430 seconds (7 minutes 10 seconds), and participant 06 
(slow flipper), at 353 seconds (5 minutes 53 seconds). Involuntary and voluntary data corruption 
aside, the future usability of the testing scenarios may be further dissected based on the quality of 
the data that was collected. 
While the binocular and monocular flipper conditions were successful at inducing 
asthenopia in every participant, the COAS data collected at each phase of the flip and recovery is 
necessary to provide accurate analysis. Unfortunately, the difficulty of producing adequate 
wavefront capture resulted in less than optimal data. Table 24 highlights the variability of 
capture rate. 
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Table 24 
Binocular Flippers Capture Rate (with highlights indicating data variability) 
Participant 
Number 
Total Images 
captured (ideal, 
based on time) 
Total 
usable 
images 
Testing 
Duration 
(min:sec) 
Capture 
Rate (%) 
01 302 171 10:04 56.6 
03 110 46 3:41 41.8 
05 215 37 7:10 17.2 
06 176 116 5:53 65.9 
07 98 16 3:16 16.3 
08 150 52 5:00 34.6 
09 68 14 2:17 20.5 
10 111 11 3:42 9.9 
 
Considering modifications for future pilot studies also prove to highlight the binocular 
and monocular flipper task’s vulnerabilities.  In this study, each participant moved the flippers at 
a unique pace, while images were captured every 2 seconds (restarts to the COAS system every 1 
minute 26 seconds notwithstanding).  Therefore, image capture as needed at every phase of the 
accommodation/recovery spectrum could easily be missed.  It may be considered that moving the 
flipper at a designated rate could force image capture at a specific time, however, this is also 
expected to fail, as a forced flip may precede the completion of the participant’s accommodative 
recovery, resulting in missing or corrupted data as well.  Therefore, while it is true that binocular 
and monocular flipper tasks are adequate in inducing asthenopia in a participant, it is not an 
effective task when the goal is of real-time analysis.  Measurements taken with these two tasks 
result with missing and variable data which is not capable of being compared between readings 
captured with control and test lenses, as future studies anticipate performing. 
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 The close working distance scenario also concluded with poor image capture results, due 
to the presence of the +5.00 DS spectacles the participants wore for the testing scenario. The 
COAS had difficulty producing quality wavefront images through the spectacles.  Table 25 
shows the poor and variable capture rate associated with the close working distance condition. 
Table 25 
Close Working Distance Capture Rate (with highlights indicating data variability) 
Participant 
Number 
Total Images 
captured (ideal, 
based on time) 
Total 
usable 
images 
Testing 
Duration 
(min:sec) 
Capture 
Rate (%) 
01 197 81 6:35 41.1 
03 145 74 4:50 51.0 
05 217 68 7:15 31.3 
06 46 31 1:32 67.4 
07 130 28 4:21 21.5 
08 450 84 15:00 18.6 
09 45 15 1:30 33.3 
10 110 26 3:41 23.6 
 
Ultimately, with future research in mind, it was the small font condition that provided the 
best option for asthenopia induction with accurate COAS wavefront detection.  The small font 
condition resulted with the most accurate paraxial accommodation on the target stimulus across 
participants, with a consistent amount of spherical aberration. Considerations may be made to the 
stimulus design itself, which in this pilot study, were designed to mimic small font designs of 
historical studies.114,115 The 1 mm sized font on the Mahjong game tiles was found to produce a 
visually acceptable, though difficult, visual scenario, creating a task which all participants were 
capable of performing, as they had normal accommodative ability and were sporting an optimal 
                                                          
114 Sheedy JE, et al. Is All Asthenopia the Same? 
115 Gowrisankaran S, et al. Eyelid Squint Response to Asthenopia-Inducing Conditions. 
150 
 
refractive correction. On average, the time to “100% barely tolerable eyestrain achieved” in the 
small font condition was 610 seconds (10 minutes 10 seconds).  This resulted with an average of 
7 cycles per participant of the COAS, with variability introduced each cycle by time lost to 
restart the system.  With less potential variability, the small font condition is the most effective 
of the testing scenarios presented in this pilot study.  
In conclusion, by limiting the duration of testing to the maximum allowed by the COAS 
in a single cycle, and by eliminating the induction stimulus categories that provided less than 
optimal wavefront image results, future studies utilizing a variation of the small font stimulus 
design and optics table set up may provide the data necessary to interpret the onset of asthenopia 
in real time. This method of measuring accommodation in real-time could then be replicated with 
control and test contact lenses, such as the Biofinity Sphere and Biofinity Energys contact lenses, 
respectively, to show if a participant is actively utilizing the add power in the lens designed to 
reduce ocular fatigue. Results could provide an investigator with a conclusion that the test 
contact lens was or was not found to objectively reduce the signs of asthenopia as defined by 
refractive state, pupil size, and spherical aberration.  Comparison to subjective data collected 
would then show if any reduction in asthenopia symptoms was due to the eye’s utilization of the 
unique contact lens optics, or due to the placebo effect. 
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Conclusions 
 The results of the pilot testing performed of the methods presented in this thesis provide 
an important increase in the knowledge of the capabilities and limitations of the COAS 
aberrometer as it may be used in the investigation of defocus, pupil size, and spherical aberration 
in real-time testing scenarios.  Analysis of the results of the four stimulus items tested revealed 
that the most promising task stimulus to induce asthenopia while collecting objective data was 
the small font condition. 
The methods outlined in this thesis to provide (1) baseline testing (with testing at optical 
infinity, and with the Mahjong game stimulus at its optimal working distance and font size), to 
(2) collect video and audio recording data via the Go-Pro Hero 4 camera (to analyze fissure 
height, and to accurately measure time to fatigue), to (3) account for possible confounding 
factors (Medmont corneal topographer use to evaluate non-invasive tear break up time), and to 
(4) correlate with subjective patient responses (Eye Frequency Rating Questionnaire), provide a 
process by which future test results may be accurately and thoroughly analyzed. 
As the use of digital devices in our daily work, school, and social lives continues to 
increase, the clinical prevalence of asthenopia will also continue to grow. Increasing our 
knowledge of the efficacy of treatment options, particularly in the underserved contact lens 
population, will prove extremely useful. 
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Appendix 1 – Case Report Forms 
 
   
0.1 SCREENING VISIT 
Date_______________          Study  Asthenopia Induction                Participant study ID________ 
 
ICL Checklist for Prospective Participant (PP) 
   ICL given to PP 
   PP given ample time to read ICL 
   PP given opportunity to ask questions 
   PP, investigator and witness correctly signed and dated ICL 
   PP given copy of ICL  
        PP declined copy of ICL  
 
History 
 
Age_____           Female   Male        
 
Current lens type: _____________________  Typical time of lens insertion: _______ am / pm (circle)  
 
Typical time of lens removal: ________  am / pm (circle)           
 
Lens wear frequency: Days/week: _____        Current care system: ___________________________ 
 
Regular use of rewetting /lubricant drops:     Yes    No       
 
Health History and medications:   Yes     None   If yes, complete 0.2 Medical History Form 
 
Allergies:       Yes     None   If yes, complete 0.2 Medical History Form 
 
Other comments:  _________________________________________________________________                                             
 
 
Complete 0.3 Pre-Study Questionnaire  yes     no 
 
Entrance Snellen VA: OD 20/____ 
           
               OS 20/____ 
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           OD               OS 
Automated 
Refraction 
Sph (±Diop) Cyl  (-Diop) Axis (Deg) Sph (±Diop) Cyl  (-Diop) Axis (Deg) 
_ . _ _ _ . _ _ _ _ _ _ . _ _ _ . _ _ _ _ _ 
Automated 
Keratometry 
H (mm) V (mm) 
Cyl  (-
Diop) 
Axis (Deg) H (mm) V (mm) 
Cyl  (-
Diop) 
Axis (Deg) 
_ . _ _ _ . _ _ _ . _ _ _ _ _ _ . _ _ _ . _ _ _ . _ _ _ _ _ 
 
Current 
Spectacle Rx 
 
Non-Invasive 
TBUT 
(Medmont) 
Sph (±Diop)         Cyl  (-Diop)               Axis (Deg) 
 
_ . _ _         _ . _ _                      _ _ _ 
 
 
1.__________2. ________3. ________ 
 
Average: ______________ 
Sph (±Diop)         Cyl  (-Diop)               Axis (Deg) 
 
_ . _ _         _ . _ _                      _ _ _ 
 
 
1.__________2. ________3. ________ 
 
Average: ______________ 
Interpupillary 
Distance 
(mm) 
 
 
_____________ 
 
 
 
 
 
Complete 0.4 Entrance Biomicroscopy Form    yes     no 
        
Vision assessment:       OD              OS 
Dry 
Subjective 
Refraction 
(HCHI) 
 
May only add 
0.25D more 
minus for 
subjective 
visual 
improvement. 
 
 
 
 
 
 
 
 
 
 
Snellen VA: 
Sph (±D) Cyl  (-D) 
Axis 
(Deg) 
VA 
(±logM) 
Sph (±D) Cyl  (-D) 
Axis 
(Deg) 
VA 
(±logM) 
_ . _ _ _ . _ _ _ _ _ _ . _ _ _ . _ _ _ . _ _ _ _ _ _ . _ _ 
 
 
20/ 
 
 
20/ 
Near Snellen 
VA (@ 40cm) 
 
20/ 
 
20/ 
 
 
 
 
 
 
                              
4M 4M HI ILLUM/HC
50 1.0 R N O V S
55 0.9 Z C R D H
60 0.8 N V S O K
65 0.7 D R Z K O
70 0.6 S N H C V
75 0.5 C R V S K
80 0.4 V K C N H
85 0.3 S V K D N
90 0.2 K D H Z C
95 0.1 H Z C O R
100 0.0 O K D H N
105 -0.1 Z O N K C
110 -0.2 R H S V D
115 -0.3 D S O R Z
4M 4M HI ILLUM/HC
50 1.0 C O H Z V
55 0.9 S Z N D C
60 0.8 V K C N R
65 0.7 K C R H N
70 0.6 Z K D V C
75 0.5 H V O R K
80 0.4 R H S O N
85 0.3 K S V R H
90 0.2 H N K C D
95 0.1 N D V K O
100 0.0 D H O S Z
105 -0.1 V R N D O
110 -0.2 C Z H K S
115 -0.3 O R Z S K
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Phoria Testing (     @ 4m) 
 
Phoria Testing (      @ 40cm) 
 
 
Phoria Testing (     @ 40cm w/+1.00D 
add) 
 
 
 
Gradient Phoria (near - gradient / +1.00) 
 
 
Base In Vergence Ranges 
(Blur/Break/Recovery) 
 
_________ / __________ / ___________ 
 
Base Out Vergence Ranges 
(Blur/Break/Recovery) 
 
_________ / __________ / ___________ 
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OD               OS 
Instillation 
1% 
Tropicamide 
Time of instillation:________________ 
Wait 30 minutes before proceeding to wet retinoscopy and refraction. 
Time of testing restarting: ____________ 
 
Wet 
Retinoscopy 
(HCHI) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Snellen VA: 
Sph (±D) Cyl  (-D) Axis (Deg) 
VA 
(±logM) 
Sph (±D) Cyl  (-D) Axis (Deg) 
VA 
(±logM) 
_ . _ _ _ . _ _ _ _ _ _ . _ _ _ . _ _ _ . _ _ _ _ _ _ . _ _ 
 
20/ 
 
20/ 
Wet 
Subjective 
Refraction 
(HCHI) 
 
May only add 
0.25D more 
minus for 
subjective 
visual 
improvement.  
 
 
 
 
 
 
 
 
 
 
Snellen VA: 
Sph (±D) Cyl  (-D) Axis (Deg) 
VA 
(±logM) 
Sph (±D) Cyl  (-D) Axis (Deg) 
VA 
(±logM) 
_ . _ _ _ . _ _ _ _ _ _ . _ _ _ . _ _ _ . _ _ _ _ _ _ . _ _ 
 
 
20/ 
 
 
20/ 
  
4M 4M HI ILLUM/HC
50 1.0 R N O V S
55 0.9 Z C R D H
60 0.8 N V S O K
65 0.7 D R Z K O
70 0.6 S N H C V
75 0.5 C R V S K
80 0.4 V K C N H
85 0.3 S V K D N
90 0.2 K D H Z C
95 0.1 H Z C O R
100 0.0 O K D H N
105 -0.1 Z O N K C
110 -0.2 R H S V D
115 -0.3 D S O R Z
4M 4M HI ILLUM/HC
50 1.0 C O H Z V
55 0.9 S Z N D C
60 0.8 V K C N R
65 0.7 K C R H N
70 0.6 Z K D V C
75 0.5 H V O R K
80 0.4 R H S O N
85 0.3 K S V R H
90 0.2 H N K C D
95 0.1 N D V K O
100 0.0 D H O S Z
105 -0.1 V R N D O
110 -0.2 C Z H K S
115 -0.3 O R Z S K
4M 4M HI ILLUM/HC
50 1.0 R N O V S
55 0.9 Z C R D H
60 0.8 N V S O K
65 0.7 D R Z K O
70 0.6 S N H C V
75 0.5 C R V S K
80 0.4 V K C N H
85 0.3 S V K D N
90 0.2 K D H Z C
95 0.1 H Z C O R
100 0.0 O K D H N
105 -0.1 Z O N K C
110 -0.2 R H S V D
115 -0.3 D S O R Z
4M 4M HI ILLUM/HC
50 1.0 C O H Z V
55 0.9 S Z N D C
60 0.8 V K C N R
65 0.7 K C R H N
70 0.6 Z K D V C
75 0.5 H V O R K
80 0.4 R H S O N
85 0.3 K S V R H
90 0.2 H N K C D
95 0.1 N D V K O
100 0.0 D H O S Z
105 -0.1 V R N D O
110 -0.2 C Z H K S
115 -0.3 O R Z S K
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INCLUSION / EXCLUSION CRITERIA 
 
Y N INCLUSION Y N EXCLUSION 
  Oculo-visual examination in the last two 
years; 
 
  Has never worn contact lenses before; 
  Between 18 and 35 years of age and has 
full legal capacity to volunteer; 
 
  Any systemic disease affecting ocular health; 
  Has read and understood the informed 
consent letter; 
 
  Is using any systemic or topical medications 
that will affect ocular health; 
  Is willing and able to follow instructions and 
maintain the appointment schedule; 
 
  Has any ocular pathology or anomaly that 
would affect the wearing of the lenses; 
  Is correctable to a visual acuity of 20/25 or 
better (in each eye) with their habitual 
correction or 20/20 best corrected; 
 
  Has persistent, clinically significant corneal or 
conjunctival staining using sodium fluorescein 
dye; 
  Currently wears, or has previously 
successfully worn, soft contact lenses 
between –0.50 and  
-6.00D;   
 
  Is aphakic; 
  Spherical Contact Lens Rx between -0.50 
and  
-6.00 and spectacle cylinder ≤ -0.75; 
 
  Has anisometropia of ≥2.00; 
  Has not worn lenses for at least 12 hours 
before the examination; 
 
  Has undergone corneal refractive surgery; 
  Has a subjective response at baseline, 
which indicates a history of eye fatigue 
symptoms of frequency at least once per 
week. 
  Has any dry eye symptoms (CLDEQ8≥12) 
     Is participating in any other type of eye related 
clinical or research study. 
      
      
 
Based on the study inclusion/exclusion criteria, is the participant suitable for this study?  Yes    No    TBD    
Is an additional screening visit required?    Yes    No    
Comments:  none 
 
Investigator signature: ______________________________   
 
 
 
Date:  
___________________ 
 
 
 
 
 
 
 
 
 
Complete 0.5 Exit Biomicroscopy Form    yes     no 
Exit Snellen VA: OD 20/____ PinHole (if needed) 20/____           
             OS 20/____ PinHole (if needed) 20/____ 
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SCREENING APPOINTMENT 
 YES* NO 
Does the participant have any medications to report? ☐   ☐  
Does the participant have any relevant past and/ or concomitant 
medical condition, past surgeries, medications to report? ☐ ☐  
Does the participant have any planned surgeries or trips to the 
hospital to report? ☐   ☐  
* If any of the questions has been answered with ‘Yes’, please complete the relevant sections below 
 
RELEVANT MEDICAL HISTORY 
1. Medical conditions / Surgeries: 
 
Start Date: 
                   ______________                  _________ 
       ☐       DD  / MM / YYYY       OR        MM / YYYY 
End Date:   
                                 ______________                  _________ 
☐  Ongoing             DD  / MM / YYYY       OR        MM / YYYY                                   
Associated medication:        ☐  Entered below         OR          ☐   None 
 
2. Medical conditions / Surgeries: 
 
Start Date: 
                   ______________                  _________ 
       ☐       DD  / MM / YYYY       OR        MM / YYYY 
End Date:   
                                 ______________                  _________ 
☐  Ongoing             DD  / MM / YYYY       OR        MM / YYYY                                    
Associated medication:        ☐  Entered below         OR          ☐   None 
 
3. Medical conditions / Surgeries: 
 
Start Date: 
                   ______________                  _________ 
     ☐         DD  / MM / YYYY       OR        MM / YYYY 
End Date:   
                                 ______________                  _________ 
☐  Ongoing             DD  / MM / YYYY       OR        MM / YYYY                                    
Associated medication:        ☐  Entered below         OR          ☐   None 
 
PRIOR AND CONCOMITANT MEDICATIONS 
 
Medication  
Time Frame 
Start Date:  ______________ 
                    DD  / MM / YYYY 
End Date:  ______________       OR       ☐        Ongoing 
                   DD  / MM / YYYY           
Administrati
on 
Dose: 
 
Unit: Route: 
 
Frequency: 
 
Indication Condition:   #__      
 
 
 
 
 
0.2 MEDICAL HISTORY FORM 
Date_______________     Study  Asthenopia Induction                Participant study ID_________ 
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Medication  
Time Frame 
Start Date:  ______________ 
                    DD  / MM / YYYY 
End Date:  ______________       OR       ☐        Ongoing 
                   DD  / MM / YYYY           
Administration 
Dose: 
 
Unit: Route: 
 
Frequency: 
 
Indication Condition:   #__      
   
Medication  
Time Frame 
Start Date:  ______________ 
                    DD  / MM / YYYY 
End Date:  ______________       OR       ☐        Ongoing 
                   DD  / MM / YYYY           
Administration 
Dose: 
 
Unit: Route: 
 
Frequency: 
 
Indication Condition:   #__      
   
Medication  
Time Frame 
Start Date:  ______________ 
                    DD  / MM / YYYY 
End Date:  ______________       OR       ☐        Ongoing 
                   DD  / MM / YYYY           
Administration 
Dose: 
 
Unit: Route: 
 
Frequency: 
 
Indication Condition:   #__      
 
DOCUMENTATION OF ALLERGIES 
Does the participant have a history of allergies to report? ☐ Yes  ☐ No 
Are there any ocular symptoms associated with the allergies, in 
general? ☐ Yes  ☐ No 
Are there currently any ocular symptoms due to allergies to report? ☐ Yes  ☐ No 
Does the participant usually require medications at the time of 
active allergies?  ☐ Yes  ☐ No 
If yes, please indicate: ☐ Redness    ☐ Itchy eyes    ☐ Watering  ☐ Sore eyes   ☐ 
Burning 
Type of 
allergy 
Drug Environment Food Other 
    
    
    
    
 
Signature: ____________________         Initials:  ______________________         Date: _________________     
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Eye Fatigue Experiences Questionnaire (@ Baseline, with habitual) 
Now we would like to ask you about eye fatigue. Eye fatigue is the physical discomfort of your eyes after 
spending periods of time throughout the day in front of a digital screen, like a computer or smartphone. 
Based on the description above, how often do you experience eye fatigue? (Select one answer.)   
Multiple 
Times Per 
Day 
Once Per 
Day 
A Few 
Times Per 
Week 
Once Per 
Week 
2-3 Times 
Per Month 
Once Per 
Month  
 
 
At Least 
Once 
Every 3  
Months 
Less 
Often 
Than 
Once 
Every 3 
Months 
I Never 
Experience 
Eye Fatigue  
         
If answered positively to experiencing fatigue (once per week or greater) 
1. On average, after you wake up, how many hours does it take before you feel that your eyes 
are getting fatigued? _____________ 
2. Which of the following symptoms best describe the sensations you experience in 
association with eye fatigue?   
a. Put a tick mark next to each sensation that you perceive in relation to digital screen use 
b. THEN.  Rank your TOP 3 ONLY in order of frequency. E.g The most frequent symptom = 
1; second most frequent =2; third most frequent = 3 
c. THEN.  Rank your TOP 3 ONLY in order of severity. E.g The most severe symptom = 1; 
second most severe =2; third most severe = 3 
d. THEN.  Rank your TOP 3 ONLY in order of how bothersome the symptom is. E.g The 
most bothersome symptom = 1; second most bothersome =2; third most bothersome= 3 
Occurs y/n Rank Symptom Occurs 
y/n 
Rank Symptom 
 
F S B 
 
F S B 
 
    Tiredness     
Text coming in and out of 
focus 
    
Heaviness around 
eyes 
    Losing your place in text  
    Pain     Text fading 
    Blurred Vision     Itchiness 
    Double Vision     Grittiness 
    Headache     Dryness 
    Sleepy     Watery eyes/Tearing 
    Pulling feeling     Soreness 
    Text Floating      Glare 
    
Other (Please 
state) 
   
0.3 Pre Study Questionnaire 
Date_______________     Study  Asthenopia Induction     Participant study ID___________ 
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Eye Fatigue Rating Questionnaire (Severity only) 
Severity  
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe                     Extreme 
On this scale of 0 to 100 how would you grade the severity of the following symptoms on 
average with computers or digital devices, with 100 representing extreme/debilitating symptoms 
and 0 representing no symptoms experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
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CLDEQ-8 
1. Questions about EYE DISCOMFORT: 
a. During a typical day in the past 2 weeks, how often did your eyes feel discomfort while 
wearing your contact lenses? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
 
b. When your eyes felt discomfort with your contact lenses, how intense was this feeling 
of discomfort at the end of your wearing time? 
 
Never have it    Not at all   Very  
have it  Intense    Intense 
0   1 2 3 4 5 
 
2. Questions about EYE DRYNESS: 
a. During a typical day in the past 2 weeks, how often did your eyes feel dry? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
 
b. When your eyes felt dry, how intense was this feeling of dryness at the end of your 
wearing time? 
 
Never have it    Not at all   Very  
have it  Intense    Intense 
0   1 2 3 4 5 
 
3. Question about CHANGEABLE, BLURRY VISION: 
a. During a typical day in the past 2 weeks, how often did your vision change between 
clear and blurry or foggy while wearing your contact lenses? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
 
b. When your vision was blurry, how noticeable with the changeable, blurry, or foggy 
vision at the end of your wearing time? 
Never have it    Not at all   Very  
have it  Intense    Intense 
0   1 2 3 4 5 
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4. Question about CLOSING YOUR EYES: 
During a typical day in the past 2 weeks, how often did your eyes bother you so much that 
you wanted to close them? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
 
5. Question about REMOVING YOUR LENSES: 
How often during the past 2 weeks, did your eyes bother you so much while wearing your contact 
lenses that you felt as if you needed to stop whatever you were doing and take out your contact 
lenses? 
                                    1          Never 
                                    2          Less than once a week 
                                    3          Weekly 
                                    4          Several times a week 
                                    5          Daily 
                                    6          Several times a day 
 
Score:   1a + 1b + 2a + 2b + 3a + 3b + 4 + 5 = Total 
  __ + __ + __ + __ + __ + __ + __ + __ = _______ 
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0.4 ENTRANCE BIOMICROSCOPY 
Date_____________                 Study  Asthenopia Induction         Participant study ID___________ 
EXTERNALADNEXA ANOMALIES OD OS 
 
Absent:          
 
Describe:________________________________ 
 
_______________________________________ 
 
   
. 
 
 
 
 
 
 
    
 
 
 
HYPEREMIA 
Bulbar  
0-4 (0.25 steps)    
  
0 None  
1 Slight injection of  
   conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
 
__ . __ __ 
 
__ . __ __ 
Limbal  
0-4 (0.25 steps)    
 
__ . __ __ 
 
__ . __ __ 
CORNEA & ANTERIOR EYE   
Scars or other corneal 
observations:  
 
Absent    Present  & Describe:       
 
_____________ 
 
__________ 
Absent   Present  & Describe:       
 
_____________ 
 
__________ 
Infiltrates:    
Size (diameter) of largest infiltrate 
 0 = none                        3 = 1 - 1.5mm 
 1 = < 0.5mm                  4 = >1.5mm 
 2 = 0.5 - 1mm 
Depth of largest infiltrate 
 0 = none                        3 = mid stromal 
 1 = epithelial                 4 = deep stromal 
 2 = sub-epithelial 
Absent    Present 
  
Complete only if 
present: 
C # ____ S ____ 
D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ 
Absent    Present 
  
Complete only if 
present: 
C # ____ S 
____ D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ STAINING                                                                OD                                          OS 
Corneal Staining 
Type, T  0-4 (0.50 steps)    
0 No staining  
1 Trace, minimal superficial diffuse staining or 
stippling,   
    or trace abrasion or foreign body tracks  
2 Mild, regional or diffuse punctate staining, or mild  
   abrasion or foreign body tracks  
3 Moderate, significant dense coalesced staining,  
   corneal abrasion or foreign body tracks  
4 Severe abrasions greater than 2mm diameter,  
   ulcerations, epithelial loss, or full thickness abrasion  
No staining in any zones    No staining in any zones    
  
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
   
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
 
Extent, E: 0-4 (1 step)    
0 No staining  
1 1-15% of area  
2 16-30% of area  
3 31-45% of area  
4 >45% of area  
TEMPORA
L 
None  
T   __ . __ 
E   __ 
D   __ . __ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
TEMPORAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
Depth, D:   0-4 (0.50 steps)  
0 No staining  
1 Superficial epithelium  
2 Deep epithelium, delayed stromal glow  
3 Immediate localized stromal glow  
4 Immediate diffuse stromal glow, or full thickness  
   abrasion  
 
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
 
  
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
 
 
MP
C
P
MP
C
P
MP
C
P
MP
C
P
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 OD OS 
 
 
Optional sketch of staining: 
 
 C NT
S
I
 
C
S
I
N T
 
Causes for Staining  Dehydration Staining:   Yes     No   Dehydration Staining:   Yes     No   
 Lens related:                 Yes     No    Lens related:                 Yes     No    
 Precursor to Seal:         Yes     No   Precursor to Seal:         Yes     No   
 
SEAL:                            Yes     No   
N/A:  
SEAL:                            Yes     No   
N/A:  
Conjunctival Staining  
(0-4; 0.5 steps) 
 
0 None 
1 Minimal diffuse punctuate 
2 Coalescent punctuate 
3 Confluent 
4 Deep confluent         
 No staining in any zones    No staining in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
Conjunctival Indentation  
(0-4; 0.5 steps)   
 
0 None 
1 Very slight 
2 Slight 
3 Moderate 
4 Severe 
 No indentation in any zones    No indentation in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
 
 
Palpebral Conjunctiva  
  
Hyperemia, H (0-4; 0.25 steps)   
0 None  
1 Slight injection of conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
Papillae, P (Roughness) (0-4; 0.25 steps)   
0 Uniform satin appearance of conjunctiva  
1 Trace, slight loss of smoothness  
2 Mild, or scattered papillae/follicles <1mm in diameter  
3 Moderate, significant papillae/follicles <1mm in 
   diameter  
4 Severe, localised or generalised papillae/ follicles 1mm 
   or more in diameter  
 Upper central area  
H   __. __ __ 
 
P   __. __ __ 
  Upper central area  
H   __. __ __ 
 
P   __. __ __ 
 
  
 Lower central area  
H   __. __ __ 
 
P   __. __ __ 
  Lower central area  
H   __. __ __ 
 
P   __. __ __ 
 
 
Comments: None     
 
Signature: 
 
                                                                Date:  
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0.5 EXIT BIOMICROSCOPY 
Date_______________              Study  Asthenopia Induction           Participant study ID___________ 
EXTERNALADNEXA ANOMALIES OD OS 
 
Absent:          
 
Describe:________________________________ 
 
_______________________________________ 
 
   
. 
 
 
 
 
 
 
    
 
 
 
HYPEREMIA 
Bulbar  
0-4 (0.25 steps)    
  
0 None  
1 Slight injection of  
   conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
 
__ . __ __ 
 
__ . __ __ 
Limbal  
0-4 (0.25 steps)    
 
__ . __ __ 
 
__ . __ __ 
CORNEA & ANTERIOR EYE   
Scars or other corneal 
observations:  
 
Absent    Present  & Describe:       
 
_____________ 
 
__________ 
Absent   Present  & Describe:       
 
_____________ 
 
__________ 
Infiltrates:    
Size (diameter) of largest infiltrate 
 0 = none                        3 = 1 - 1.5mm 
 1 = < 0.5mm                  4 = >1.5mm 
 2 = 0.5 - 1mm 
Depth of largest infiltrate 
 0 = none                        3 = mid stromal 
 1 = epithelial                 4 = deep stromal 
 2 = sub-epithelial 
Absent    Present 
  
Complete only if 
present: 
C # ____ S ____ 
D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ 
Absent    Present 
  
Complete only if 
present: 
C # ____ S 
____ D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ STAINING                                                                OD                                          OS 
Corneal Staining 
Type, T  0-4 (0.50 steps)    
0 No staining  
1 Trace, minimal superficial diffuse staining or 
stippling,   
    or trace abrasion or foreign body tracks  
2 Mild, regional or diffuse punctate staining, or mild  
   abrasion or foreign body tracks  
3 Moderate, significant dense coalesced staining,  
   corneal abrasion or foreign body tracks  
4 Severe abrasions greater than 2mm diameter,  
   ulcerations, epithelial loss, or full thickness abrasion  
No staining in any zones    No staining in any zones    
  
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
   
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
 
Extent, E: 0-4 (1 step)    
0 No staining  
1 1-15% of area  
2 16-30% of area  
3 31-45% of area  
4 >45% of area  
TEMPORA
L 
None  
T   __ . __ 
E   __ 
D   __ . __ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
TEMPORAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
Depth, D:   0-4 (0.50 steps)  
0 No staining  
1 Superficial epithelium  
2 Deep epithelium, delayed stromal glow  
3 Immediate localized stromal glow  
4 Immediate diffuse stromal glow, or full thickness  
   abrasion  
 
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
 
  
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
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 OD OS 
 
 
Optional sketch of staining: 
 
 C NT
S
I
 
C
S
I
N T
 
Causes for Staining  Dehydration Staining:   Yes     No   Dehydration Staining:   Yes     No   
 Lens related:                 Yes     No    Lens related:                 Yes     No    
 Precursor to Seal:         Yes     No   Precursor to Seal:         Yes     No   
 
SEAL:                            Yes     No   
N/A:  
SEAL:                            Yes     No   
N/A:  
Conjunctival Staining  
(0-4; 0.5 steps) 
 
0 None 
1 Minimal diffuse punctuate 
2 Coalescent punctuate 
3 Confluent 
4 Deep confluent         
 No staining in any zones    No staining in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
Conjunctival Indentation  
(0-4; 0.5 steps)   
 
0 None 
1 Very slight 
2 Slight 
3 Moderate 
4 Severe 
 No indentation in any zones    No indentation in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
 
 
Palpebral Conjunctiva  
  
Hyperemia, H (0-4; 0.25 steps)   
0 None  
1 Slight injection of conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
Papillae, P (Roughness) (0-4; 0.25 steps)   
0 Uniform satin appearance of conjunctiva  
1 Trace, slight loss of smoothness  
2 Mild, or scattered papillae/follicles <1mm in diameter  
3 Moderate, significant papillae/follicles <1mm in 
   diameter  
4 Severe, localised or generalised papillae/ follicles 1mm 
   or more in diameter  
 Upper central area  
H   __. __ __ 
 
P   __. __ __ 
  Upper central area  
H   __. __ __ 
 
P   __. __ __ 
 
  
 Lower central area  
H   __. __ __ 
 
P   __. __ __ 
  Lower central area  
H   __. __ __ 
 
P   __. __ __ 
 
 
Comments: None     
 
Signature: 
 
                                                                Date:  
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1.1 Asthenopia Induction Trial 
Date_________          Study  Asthenopia Induction                Participant study ID________ 
 
 
Since the participant’s last visit, have they experienced any of the following (if “Y”, describe in 
space provided): 
Problems with their eyes or vision? ☐N ☐Y  
Changes to their health? ☐N ☐Y   If “Y”, complete Medical History Form 
Changes to their concomitant medication(s)? ☐N ☐Y   If “Y”, complete Medical History Form 
   
   
   
Does the problem/change represent an 
adverse event? 
☐
N/A 
☐
N 
☐
Y 
If “Y”, complete AE Events Forms 
 
Entrance Snellen VA 
OD OS 
20/_____ 20/_____ 
Non-Invasive TBUT 
(Medmont) 
 
1.__________2. ________3. ________ 
Average: ______________ 
 
1.__________2. ________3. ________ 
Average: ______________ 
 
 Does The participant meet the study inclusion criteria?  yes     no 
 
Complete 1.2 Entrance Biomicroscopy Form  yes     no 
 
Investigator to insert Biofinity Sphere (Base Curve 8.6, Diameter 14.0)  
(Power empirically calculated according to vertexed cycloplegic refraction)  yes     no 
 
 OD OS 
Lens power (Diop) _ . _ _ _ . _ _ 
Lens fit acceptable?  
(if “no”, participant will discontinue)  yes     no  yes     no 
 
5min settling period 
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Vision assessment 
     OD      OS 
With CL 4m 40cm 
HI HCVA 
(logMAR) 
OD OS OD OS 
_ . _ _ _ . _ _ _ . _ _ _ . _ _ 
HI HCVA 
(logMAR)  4m 
 
 
 
HI HCVA 
(logMAR)  
40cm 
Near
1.3 C O H Z V
1.2 S Z N D C
1.1 V K C N R
1 K C R H N
0.9 Z K D V C
0.8 H V O R K
0.7 R H S O N
0.6 K S V R H
0.5 H N K C D
0.4 N D V K O
0.3 D H O S Z
0.2 V R N D O
0.1 C Z H K S
0 O R Z S K
-0.1 S C N D Z
-0.2 N D H K C
-0.3 V K O R H
LogMAR
Hi Illum/HC OD
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4M 4M HI ILLUM/HC
50 1.0 R N O V S
55 0.9 Z C R D H
60 0.8 N V S O K
65 0.7 D R Z K O
70 0.6 S N H C V
75 0.5 C R V S K
80 0.4 V K C N H
85 0.3 S V K D N
90 0.2 K D H Z C
95 0.1 H Z C O R
100 0.0 O K D H N
105 -0.1 Z O N K C
110 -0.2 R H S V D
115 -0.3 D S O R Z
4M 4M HI ILLUM/HC
50 1.0 C O H Z V
55 0.9 S Z N D C
60 0.8 V K C N R
65 0.7 K C R H N
70 0.6 Z K D V C
75 0.5 H V O R K
80 0.4 R H S O N
85 0.3 K S V R H
90 0.2 H N K C D
95 0.1 N D V K O
100 0.0 D H O S Z
105 -0.1 V R N D O
110 -0.2 C Z H K S
115 -0.3 O R Z S K
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     OD      OS 
Baseline 
Non-Invasive 
TBUT (with 
CLs) (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
Participant to complete 1.3 Pre-Testing Subjective Questionnaire  yes     no 
 
Distance Baseline Measures:                          yes     no 
(1 minute of viewing target at optical infinity) 
 
Baseline Measures: 
(15 minutes of sitting in study configuration: iPhone positioned @ 40cm) 
Post-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
Participant to complete 1.4 Asthenopia Induction Technique 1   yes     no 
 
Participant to complete 1.5 Asthenopia Induction Technique 2   yes     no 
 
Participant to complete 1.6 Asthenopia Induction Technique 3   yes     no 
 
Post-Testing Measures: 
(15 minutes of sitting in study configuration: iPhone positioned @ 40cm) 
Post-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
Participant to complete 1.7 Post-Testing Subjective Questionnaire  yes     no 
 
Investigator to remove and discard lenses  yes     no 
 
Complete 1.8 Exit Biomicroscopy Form  yes     no 
 
Exit Snellen VA: OD 20/____          
        OS 20/___
 
1.1 Asthenopia Induction Trial 
Date_________          Study  Asthenopia Induction                Participant study ID________ 
Were any adverse events observed during the study visit?  yes     no If “yes”, complete AE 
Event Form 
Is the participant eligible to continue in the study?  yes     no    TBD 
If N, please describe reason(s) and indicate if discontinued: 
Investigator signature: _________________________________                                 
Date:____________________ 
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1.2 ENTRANCE BIOMICROSCOPY 
Date______________        Study  Asthenopia Induction                Participant study ID___________ 
EXTERNALADNEXA ANOMALIES OD OS 
 
Absent:          
 
Describe:________________________________ 
 
_______________________________________ 
 
   
. 
 
 
 
 
 
 
    
 
 
 
HYPEREMIA 
Bulbar  
0-4 (0.25 steps)    
  
0 None  
1 Slight injection of  
   conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
 
__ . __ __ 
 
__ . __ __ 
Limbal  
0-4 (0.25 steps)    
 
__ . __ __ 
 
__ . __ __ 
CORNEA & ANTERIOR EYE   
Scars or other corneal 
observations:  
 
Absent    Present  & Describe:       
 
_____________ 
 
__________ 
Absent   Present  & Describe:       
 
_____________ 
 
__________ 
Infiltrates:    
Size (diameter) of largest infiltrate 
 0 = none                        3 = 1 - 1.5mm 
 1 = < 0.5mm                  4 = >1.5mm 
 2 = 0.5 - 1mm 
Depth of largest infiltrate 
 0 = none                        3 = mid stromal 
 1 = epithelial                 4 = deep stromal 
 2 = sub-epithelial 
Absent    Present 
  
Complete only if 
present: 
C # ____ S ____ 
D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ 
Absent    Present 
  
Complete only if 
present: 
C # ____ S 
____ D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ STAINING                                                                OD                                          OS 
Corneal Staining 
Type, T  0-4 (0.50 steps)    
0 No staining  
1 Trace, minimal superficial diffuse staining or 
stippling,   
    or trace abrasion or foreign body tracks  
2 Mild, regional or diffuse punctate staining, or mild  
   abrasion or foreign body tracks  
3 Moderate, significant dense coalesced staining,  
   corneal abrasion or foreign body tracks  
4 Severe abrasions greater than 2mm diameter,  
   ulcerations, epithelial loss, or full thickness abrasion  
No staining in any zones    No staining in any zones    
  
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
   
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
 
Extent, E: 0-4 (1 step)    
0 No staining  
1 1-15% of area  
2 16-30% of area  
3 31-45% of area  
4 >45% of area  
TEMPORA
L 
None  
T   __ . __ 
E   __ 
D   __ . __ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
TEMPORAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
Depth, D:   0-4 (0.50 steps)  
0 No staining  
1 Superficial epithelium  
2 Deep epithelium, delayed stromal glow  
3 Immediate localized stromal glow  
4 Immediate diffuse stromal glow, or full thickness  
   abrasion  
 
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
 
  
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
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 OD OS 
 
 
Optional sketch of staining: 
 
 C NT
S
I
 
C
S
I
N T
 
Causes for Staining  Dehydration Staining:   Yes     No   Dehydration Staining:   Yes     No   
 Lens related:                 Yes     No    Lens related:                 Yes     No    
 Precursor to Seal:         Yes     No   Precursor to Seal:         Yes     No   
 
SEAL:                            Yes     No   
N/A:  
SEAL:                            Yes     No   
N/A:  
Conjunctival Staining  
(0-4; 0.5 steps) 
 
0 None 
1 Minimal diffuse punctuate 
2 Coalescent punctuate 
3 Confluent 
4 Deep confluent         
 No staining in any zones    No staining in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
Conjunctival Indentation  
(0-4; 0.5 steps)   
 
0 None 
1 Very slight 
2 Slight 
3 Moderate 
4 Severe 
 No indentation in any zones    No indentation in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
 
 
Palpebral Conjunctiva  
  
Hyperemia, H (0-4; 0.25 steps)   
0 None  
1 Slight injection of conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
Papillae, P (Roughness) (0-4; 0.25 steps)   
0 Uniform satin appearance of conjunctiva  
1 Trace, slight loss of smoothness  
2 Mild, or scattered papillae/follicles <1mm in diameter  
3 Moderate, significant papillae/follicles <1mm in 
   diameter  
4 Severe, localised or generalised papillae/ follicles 1mm 
   or more in diameter  
 Upper central area  
H   __. __ __ 
 
P   __. __ __ 
  Upper central area  
H   __. __ __ 
 
P   __. __ __ 
 
  
 Lower central area  
H   __. __ __ 
 
P   __. __ __ 
  Lower central area  
H   __. __ __ 
 
P   __. __ __ 
 
 
Comments: None     
 
Signature: 
 
                                                                Date:  
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1.3 Pre-Testing Subjective  Questionnaire – Asthenopia Induction Trial 
Date_______________     Study  Asthenopia Induction     Participant study ID___________ 
 
Pre-Testing - Eye Fatigue Rating Questionnaire (Severity only) 
Participant is to answer questions based on “overall” or “average” daily symptoms. 
Severity 
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe            Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms on average 
with computers or digital devices, with 100 representing extreme/debilitating symptoms and 0 
representing no symptoms experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
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Induction Technique (Randomized) 
(Circle)  Close WD Flippers Small Font 
 
Measurements to be taken prior to technique: 
 
     OD      OS 
Investigator 
Lens Surface 
Rating 
  
Pre-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
Eye Fatigue Rating Questionnaire: Severity after Baseline Testing 
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe  
 Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms after the Baseline 
Testing, with 100 representing extreme/debilitating symptoms and 0 representing no symptoms 
experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
Begin Induction Technique; start 15 minute countdown timer. 
 
Time participant stops playing game: _______________ (max 15 minutes) 
 
If 15 minutes is reached: 
Percent of “Barely Tolerable Eyestrain” achieved after 15 minutes of testing: 
 
0   25   50   75   100 
No discomfort          Unable to continue task  
experienced          due to discomfort 
 
 
 
 
 
 
1.4 Induction Trial 1 
Date_____________ Study  Asthenopia Induction                Participant study ID_________ 
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Game Scores: 
 
Total Number of Stars Achieved:______________ 
 
Time to Complete Puzzles: (Note any incomplete puzzles) 
Puzzle 1: Puzzle 8: Puzzle 15: 
Puzzle 2: Puzzle 9: Puzzle 16: 
Puzzle 3: Puzzle 10: Puzzle 17: 
Puzzle 4: Puzzle 11: Puzzle 18: 
Puzzle 5: Puzzle 12: Puzzle 19: 
Puzzle 6: Puzzle 13: Puzzle 20: 
Puzzle 7: Puzzle 14: Puzzle 21: 
 
 
Post-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
15 minute break for rest and post-induction questionnaire. 
 
Eye Fatigue Rating Questionnaire: Severity after Induction Test 1 
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe  
 Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms during the last 
testing period, with 100 representing extreme/debilitating symptoms and 0 representing no symptoms 
experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
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Induction Technique (Randomized) 
(Circle)  Close WD Flippers Small Font 
 
Measurements to be taken prior to technique: 
 
     OD      OS 
Investigator 
Lens Surface 
Rating 
  
Pre-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
Eye Fatigue Rating Questionnaire: Severity before beginning Induction Test 2 
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe  
 Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms right now, with 
100 representing extreme/debilitating symptoms and 0 representing no symptoms experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
Begin Induction Technique; start 15 minute countdown timer.. 
 
Time participant stops playing game: _______________ (max 15 minutes) 
 
If 15 minutes is reached: 
Percent of “Barely Tolerable Eyestrain” achieved after 15 minutes of testing: 
 
0   25   50   75   100 
  
No discomfort          Unable to continue task  
experienced          due to discomfort 
 
 
 
 
 
 
1.5 Induction Trial 2 
Date_______________         Study  Asthenopia Induction                Participant study ID___________ 
176 
 
 
Game Scores: 
 
Total Number of Stars Achieved:______________ 
 
Time to Complete Puzzles:  (Note any incomplete puzzles) 
Puzzle 1: Puzzle 8: Puzzle 15: 
Puzzle 2: Puzzle 9: Puzzle 16: 
Puzzle 3: Puzzle 10: Puzzle 17: 
Puzzle 4: Puzzle 11: Puzzle 18: 
Puzzle 5: Puzzle 12: Puzzle 19: 
Puzzle 6: Puzzle 13: Puzzle 20: 
Puzzle 7: Puzzle 14: Puzzle 21: 
 
Post-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
15 minute break for rest and post-induction questionnaire. 
 
Eye Fatigue Rating Questionnaire: Severity after Induction Test 2 
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe  
 Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms during the last 
testing period, with 100 representing extreme/debilitating symptoms and 0 representing no symptoms 
experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
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Induction Technique (Randomized) 
(Circle)  Close WD Flippers Small Font 
 
Measurements to be taken prior to technique: 
 
     OD      OS 
Investigator 
Lens Surface 
Rating 
  
Pre-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
Eye Fatigue Rating Questionnaire: Severity before beginning Induction Test 3 
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe  
 Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms right now, with 
100 representing extreme/debilitating symptoms and 0 representing no symptoms experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
 
Begin Induction Technique; start 15 minute countdown timer.. 
 
Time participant stops playing game: _______________ (max 15 minutes) 
 
If 15 minutes is reached: 
Percent of “Barely Tolerable Eyestrain” achieved after 15 minutes of testing: 
 
0   25   50   75   100 
No discomfort          Unable to continue task  
experienced          due to discomfort 
 
 
 
 
 
 
1.6 Induction Trial 3 
Date_______________          Study  Asthenopia Induction                Participant study ID___________ 
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Game Scores: 
 
Total Number of Stars Achieved:______________ 
 
Time to Complete Puzzles:  (Note any incomplete puzzles) 
Puzzle 1: Puzzle 8: Puzzle 15: 
Puzzle 2: Puzzle 9: Puzzle 16: 
Puzzle 3: Puzzle 10: Puzzle 17: 
Puzzle 4: Puzzle 11: Puzzle 18: 
Puzzle 5: Puzzle 12: Puzzle 19: 
Puzzle 6: Puzzle 13: Puzzle 20: 
Puzzle 7: Puzzle 14: Puzzle 21: 
 
Post-Test: 
Non-Invasive 
TBUT (s) 
(Medmont) 
1.__________2. ________3. ________ 
 
Average: ______________ 
1.__________2. ________3. ________ 
 
Average: ______________ 
 
15 minute break for rest and post-induction questionnaire. 
 
Eye Fatigue Rating Questionnaire: Severity during Induction Test 3 
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe  
 Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms during the last 
testing period, with 100 representing extreme/debilitating symptoms and 0 representing no symptoms 
experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
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1.7 Post-Testing Subjective  Questionnaire – Asthenopia Induction Trial 
Date_______________      Study  Asthenopia Induction    Participant study ID___________ 
 
Pre-Testing - Eye Fatigue Rating Questionnaire (Severity only) 
Participant is to answer questions based on current symptoms after today’s testing. 
Severity  
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe         Extreme 
On a scale of 0 to 100 how would you grade the severity of the following symptoms after all of 
today’s testing, with 100 representing extreme/debilitating symptoms and 0 representing no 
symptoms experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading ___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
 
 
 
180 
 
1.8 EXIT BIOMICROSCOPY 
Date_______________            Study  Asthenopia Induction                Participant study ID___________ 
EXTERNALADNEXA ANOMALIES OD OS 
 
Absent:          
 
Describe:________________________________ 
 
_______________________________________ 
 
   
. 
 
 
 
 
 
 
    
 
 
 
HYPEREMIA 
Bulbar  
0-4 (0.25 steps)    
  
0 None  
1 Slight injection of  
   conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
 
__ . __ __ 
 
__ . __ __ 
Limbal  
0-4 (0.25 steps)    
 
__ . __ __ 
 
__ . __ __ 
CORNEA & ANTERIOR EYE   
Scars or other corneal 
observations:  
 
Absent    Present  & Describe:       
 
_____________ 
 
__________ 
Absent   Present  & Describe:       
 
_____________ 
 
__________ 
Infiltrates:    
Size (diameter) of largest infiltrate 
 0 = none                        3 = 1 - 1.5mm 
 1 = < 0.5mm                  4 = >1.5mm 
 2 = 0.5 - 1mm 
Depth of largest infiltrate 
 0 = none                        3 = mid stromal 
 1 = epithelial                 4 = deep stromal 
 2 = sub-epithelial 
Absent    Present 
  
Complete only if 
present: 
C # ____ S ____ 
D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ 
Absent    Present 
  
Complete only if 
present: 
C # ____ S 
____ D ____ 
MP#____ S____ D ____ 
P# ____ S ____ D ____ STAINING                                                                OD                                          OS 
Corneal Staining 
Type, T  0-4 (0.50 steps)    
0 No staining  
1 Trace, minimal superficial diffuse staining or 
stippling,   
    or trace abrasion or foreign body tracks  
2 Mild, regional or diffuse punctate staining, or mild  
   abrasion or foreign body tracks  
3 Moderate, significant dense coalesced staining,  
   corneal abrasion or foreign body tracks  
4 Severe abrasions greater than 2mm diameter,  
   ulcerations, epithelial loss, or full thickness abrasion  
No staining in any zones    No staining in any zones    
  
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
   
SUPERIOR 
None   
T   __ . __ 
E   __ 
D   __ . __ 
 
Extent, E: 0-4 (1 step)    
0 No staining  
1 1-15% of area  
2 16-30% of area  
3 31-45% of area  
4 >45% of area  
TEMPORA
L 
None  
T   __ . __ 
E   __ 
D   __ . __ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
NASAL 
None  
T   __ . __ 
E   __ 
D   __ . 
__ 
CENTRAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
TEMPORAL 
None  
T   __ . __ 
E   __ 
D   __ . __ 
Depth, D:   0-4 (0.50 steps)  
0 No staining  
1 Superficial epithelium  
2 Deep epithelium, delayed stromal glow  
3 Immediate localized stromal glow  
4 Immediate diffuse stromal glow, or full thickness  
   abrasion  
 
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
 
  
 
INFERIOR 
None  
T   __ . __ 
E   __ 
D   __ . __ 
 
 
MP
C
P
MP
C
P
MP
C
P
MP
C
P
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 OD OS 
 
 
Optional sketch of staining: 
 
 C NT
S
I
 
C
S
I
N T
 
Causes for Staining  Dehydration Staining:   Yes     No   Dehydration Staining:   Yes     No   
 Lens related:                 Yes     No    Lens related:                 Yes     No    
 Precursor to Seal:         Yes     No   Precursor to Seal:         Yes     No   
 
SEAL:                            Yes     No   
N/A:  
SEAL:                            Yes     No   
N/A:  
Conjunctival Staining  
(0-4; 0.5 steps) 
 
0 None 
1 Minimal diffuse punctuate 
2 Coalescent punctuate 
3 Confluent 
4 Deep confluent         
 No staining in any zones    No staining in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
Conjunctival Indentation  
(0-4; 0.5 steps)   
 
0 None 
1 Very slight 
2 Slight 
3 Moderate 
4 Severe 
 No indentation in any zones    No indentation in any zones    
Nasal ___ . ___ ___ . ___ 
Temporal ___ . ___ ___ . ___ 
Superior ___ . ___ ___ . ___ 
Inferior ___ . ___ ___ . ___ 
 
 
Palpebral Conjunctiva  
  
Hyperemia, H (0-4; 0.25 steps)   
0 None  
1 Slight injection of conjunctival vessels  
2 Mild injection  
3 Moderate injection  
4 Severe injection 
Papillae, P (Roughness) (0-4; 0.25 steps)   
0 Uniform satin appearance of conjunctiva  
1 Trace, slight loss of smoothness  
2 Mild, or scattered papillae/follicles <1mm in diameter  
3 Moderate, significant papillae/follicles <1mm in 
   diameter  
4 Severe, localised or generalised papillae/ follicles 1mm 
   or more in diameter  
 Upper central area  
H   __. __ __ 
 
P   __. __ __ 
  Upper central area  
H   __. __ __ 
 
P   __. __ __ 
 
  
 Lower central area  
H   __. __ __ 
 
P   __. __ __ 
  Lower central area  
H   __. __ __ 
 
P   __. __ __ 
 
 
Comments: None     
 
Signature: 
 
                                                                Date:  
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Appendix 2 - Questionnaires 
Eye Fatigue Experiences Questionnaire (@ Baseline, with habitual) 
Now we would like to ask you about eye fatigue. Eye fatigue is the physical discomfort of your 
eyes after spending periods of time throughout the day in front of a digital screen, like a 
computer or smartphone. 
Based on the description above, how often do you experience eye fatigue? (Select one answer.)   
Multiple 
Times Per 
Day 
Once Per 
Day 
A Few 
Times Per 
Week 
Once Per 
Week 
2-3 Times 
Per Month 
Once Per 
Month  
 
 
At Least 
Once 
Every 3  
Months 
Less 
Often 
Than 
Once 
Every 3 
Months 
I Never 
Experience 
Eye Fatigue  
         
If answered positively to experiencing fatigue (once per week or greater) 
1. On average, after you wake up, how many hours does it take before you feel that your eyes 
are getting fatigued? _____________ 
 
2. Which of the following symptoms best describe the sensations you experience in association 
with eye fatigue?   
a. Put a tick mark next to each sensation that you perceive in relation to digital screen use 
b. THEN.  Rank your TOP 3 ONLY in order of frequency. E.g The most frequent symptom 
= 1; second most frequent =2; third most frequent = 3 
c. THEN.  Rank your TOP 3 ONLY in order of severity. E.g The most severe symptom = 1; 
second most severe =2; third most severe = 3 
d. THEN.  Rank your TOP 3 ONLY in order of how bothersome the symptom is. E.g The 
most bothersome symptom = 1; second most bothersome =2; third most bothersome= 3 
Occurs y/n Rank Symptom Occurs y/n Rank Symptom 
 
F S B 
 
F S B 
 
    Tiredness 
 
   
Text coming in and out of 
focus 
    
Heaviness around 
eyes 
 
   Losing your place in text  
    Pain     Text fading 
    Blurred Vision     Itchiness 
    Double Vision     Grittiness 
    Headache     Dryness 
    Sleepy     Watery eyes/Tearing 
    Pulling feeling     Soreness 
    Text Floating      Glare 
    
Other (Please 
state) 
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Eye Fatigue Rating Questionnaire (Severity only) - EFRQ 
Severity  
0□   25□   50□   75□   100□ 
None   Mild     Moderate  Severe                     Extreme 
On this scale of 0 to 100 how would you grade the severity of the following symptoms on 
average with computers or digital devices, with 100 representing extreme/debilitating symptoms 
and 0 representing no symptoms experienced: 
1. Burning ___________ 
2. Tired eyes ___________  
3. Eye pain ___________  
4. Eye ache or strain ____________ 
5. Eye irritation ___________  
6. Tearing/watery eyes ___________  
7. Blurry or double vision, or a struggle to keep letters or words clear while reading 
___________  
8. Soreness in eyes ___________  
9. Dryness in eyes ___________  
10. Headaches ___________  
11. Words or letters appearing to move or float when reading ___________  
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CLDEQ-8 
1. Questions about EYE DISCOMFORT: 
a. During a typical day in the past 2 weeks, how often did your eyes feel discomfort 
while wearing your contact lenses? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
 
b. When your eyes felt discomfort with your contact lenses, how intense was this 
feeling of discomfort at the end of your wearing time? 
 
Never have it    Not at all   Very  
have it  Intense    Intense 
0   1 2 3 4 5 
 
2. Questions about EYE DRYNESS: 
a. During a typical day in the past 2 weeks, how often did your eyes feel dry? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
 
b. When your eyes felt dry, how intense was this feeling of dryness at the end of 
your wearing time? 
 
Never have it    Not at all   Very  
have it  Intense    Intense 
0   1 2 3 4 5 
 
3. Question about CHANGEABLE, BLURRY VISION: 
a. During a typical day in the past 2 weeks, how often did your vision change 
between clear and blurry or foggy while wearing your contact lenses? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
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b. When your vision was blurry, how noticeable with the changeable, blurry, or 
foggy vision at the end of your wearing time? 
Never have it    Not at all   Very  
have it  Intense    Intense 
0   1 2 3 4 5 
 
 
4. Question about CLOSING YOUR EYES: 
During a typical day in the past 2 weeks, how often did your eyes bother you so much 
that you wanted to close them? 
0 Never 
1 Rarely 
2 Sometimes 
3 Frequently 
4 Constantly 
 
5. Question about REMOVING YOUR LENSES: 
How often during the past 2 weeks, did your eyes bother you so much while wearing your 
contact lenses that you felt as if you needed to stop whatever you were doing and take 
out your contact lenses? 
                                    1          Never 
                                    2          Less than once a week 
                                    3          Weekly 
                                    4          Several times a week 
                                    5          Daily 
                                    6          Several times a day 
 
Score:   1a + 1b + 2a + 2b + 3a + 3b + 4 + 5 = Total 
  __ + __ + __ + __ + __ + __ + __ + __ = _______ 
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Survey Question Asked if 15 Minutes of Withstanding Asthenopia Induction Technique 
was Achieved 
Percent of “Barely Tolerable Eyestrain” achieved after 15 minutes of testing: 
 
0   25   50   75   100 
No discomfort           Unable to continue task  
experienced           due to discomfort 
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Appendix 3 – Operating Procedures for Testing Stimulus 
(1) Standard Operating Procedures for Connecting MacBook and iPhone via TeamViewer 
1. Open TeamViewer on the MacBook Pro 
2. Open TeamViewer on the iPhone 
 
 
These screens will open: 
MacBook Pro       iPhone 
 
 
 
 
 
 
                                                                                  
3.  This ID number should populate automatically.  
If not, type in the “Your ID” number presented on the computer screen. 
4. Press “Remote Control” 
5. The iPhone screen will prompt you to enter the Password.  
Note that this Password may change with each login session. 
 
 
 
 188 
 
 
6. The screens on both the MacBook Pro and iPhone will change. 
MacBook     iPhone 
                                          Note: This instructions screen may show up on the iPhone.  
                                                 Click Continue.                                           
 
 
 
                  Next, rotate the iPhone screen to full screen: 
 
 
 
 
7. Move the Cursor on the iPhone Touchscreen to the far right of the screen, where it is 
out of the way. This is the LAST touch you make on the iPhone until you want to 
disconnect. 
8. Open Mahjong Solitaire Epic on the MacBook Pro Desktop. Follow the instructions 
on the Standard Operating Procedures for Mahjong Game (below) for running the 
game. 
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9. The participant will be viewing the iPhone screen, while controlling the game with 
the Apple Magic TrackPad (wirelessly connected to the MacBook Pro, and 
functioning as a mouse).  
10. To Disconnect: 
Click on the keyboard icon in the lower right corner to reveal the TeamViewer setting 
options.  
To Exit, press the X. 
 
This screen will show:  
              
 
                                                                                   Select Close. 
11. Lastly, a Pop Up with “Sponsored session” will appear on both the MacBook and 
iPhone. Simply click OK to make the screens disappear. 
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(2) Standard Operating Procedures for Mahjong Game 
1. Open Mahjong Game via icon on desktop 
 
2. Show participant game instructions (see below) and allow them to ask questions. The 
goal is for them to be playing as close to continually as possible throughout the testing 
session, so they will be solving multiple puzzles.  
3. After each session, you must manually record the data for the participant, as it will be 
OVERWRITTEN by each subsequent subject.
 
This “HOME” button is always visible during gameplay. Select the HOME icon to find 
the MAIN MENU. 
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Select the BOARDS icon to find the time statistics. 
 
 
NOTE: The last game that had been played will be highlighted in RED on the BOARDS 
screen. 
NOTE: If the board being worked on was INCOMPLETE when the experiment was 
stopped (either due to patient discomfort or 15 minute session completion) the time 
WILL NOT be recorded on the BOARDS screen.   
          - This is irrelevant if the patient reached 15 minutes. 
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There is a clock on the lower right hand corner of the screen.  NOTE THE TIME when 
the participant stops the experiment and WRITE IT DOWN. 
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(3) Instructions for playing Mahjong 
Mahjong is a matching game, using tiles with letters and numbers.  
The goal is to find matching lit up tiles, then click them both to remove them. 
 
As matching tiles are eliminated, new tiles will light up. The goal is to remove all the tiles in the 
quickest amount of time. 
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Occasionally there will be no pairs of matching tiles available. Then you must select shuffle to 
continue.  
 
After you have completed one set of tiles, you should continue with a new board.  
We will want to you to play A DIFFERENT board every time.  Your times to completion will be 
recorded for this experiment. 
 
If you find that your eyes are straining more than what you would consider “barely tolerable” 
Please stop and tell the researcher AT ANY TIME.   
If you are not having any eyestrain symptoms, you will play the game continuously for 15 
minutes. The researcher will stop you at the conclusion of the session. 
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Appendix 4 – Operating Procedures for GoPro Hero 4 Silver Edition 
Equipment: 
1 GoPro Hero 4 Silver Edition Camera 
1 Case/Stand 
2 Batteries 
2 64GB SanDisk Extreme PLUS Micro SD Cards 
1 SanDisk Micro SD Adapter 
2 USB Cables 
1 Wall Charger 
Settings: 
Video Mode 
30 FPS 
1080 Video Resolution 
Narrow FOV 
Instructions - Using the Camera During Testing: 
1. Power on: Press front Power/Mode button once. The camera status lights will flash red 
three times and emit 3 beeps. The screen will display information, indicating that the 
camera is on. 
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2. Confirm settings: Look on the bottom left of the back screen. Setting should read:  
1080 / 30 / Narrow. 
a. If the settings are incorrect: press the settings button on the right side of the 
camera. Scroll through the settings options until the settings listed above are 
chosen. 
 
 
3. Position camera on tripod 22cm from subject’s left eye. Ensure the participants LEFT eye 
is centered in the camera view when the participant is positioned properly with the bite 
bar. 
4. Take photograph of eye in looking at distance target. 
a. Swipe LEFT on the touchscreen to open the options screen 
b. Select Single 
c. Press the top Shutter/Select button once.  The camera will beep two times and 
the lights will flash. The counter on the camera status screen will increase by one. 
i. NOTE: When the camera is in the case on the stand, this button (on the 
TOP of the camera) is covered with a silver button.  
 
 
 
 
 
 197 
 
5. When ready to start the experiment video recording:  
a. Swipe LEFT on the touchscreen to open the options screen 
b. Select Video 
 
 
c. Visually confirm the settings on the bottom left of the back screen. Setting should 
read:  
1080 / 30 / Narrow. If it does not, return to step 2.  
d. Press the top Shutter/Select button once (see image above).  The camera will 
beep once and the lights will flash while the camera is recording. 
e. Before commencing the experiment: STATE ALOUD 
i. Participant Number 
ii. Condition (e.g. Baseline at distance, baseline at near, induction 
technique, or post testing) 
6. To stop recording: Press the Shutter/Select button (see step 4c) once. The lights will 
flash three times and beep three times. 
7. Repeat steps 4-6 for each testing condition. 
8. Power off: Press and hold Power/Mode button (see step 1) for 2 seconds. The lights will 
flash red and beep seven times. The screen will go black. 
Instructions – Retrieving Video Data onto Computer: 
1. This should be performed after each participant has completed their  
visit. 
2. Connect camera to computer via USB cable.  
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3. Copy files to computer: 
a. Study Folder 
b. Subject Number Folder 
c. Video file saved with this format: STUDY_SUBJECT 
NUMBER_INDUCTION TECHNIQUE_DATE 
4. Content can be played back using the GoPro software (downloaded onto the laptops) or 
via playback option on the camera itself (see below, before deleting with Trashcan icon). 
a. Confirm quality of video recording. 
5. Video files should be deleted off the camera once the file transfer is complete.  
a. Swipe LEFT on the touchscreen to open the options screen 
b. Select Playback 
c. Select the Video file you wish to delete  
d. Press the Trashcan icon to delete 
e. To return to the video screen, select the Squares icon (bottom right) and then the 
Exit icon (top right) 
6. Turn off camera once data transfer is complete (see instructions above). 
Instructions – Charging the Camera: 
1. After EACH USE the camera should be returned to the charging station, as the battery 
life is 2 hours. 
2. Connect the camera via USB cable (see above) to the wall charger. Plug in for 2 hours for 
a complete charge.  
3. Remember to lock up the unit in the cabinet at the end of the day. If the charge was not 
complete, at the beginning of the day, connect the charger before subjects arrive. 
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Appendix 5 – Font Size Conversion 
Mathematical conversion of 5 point Verdana font at 60cm working distance to Mahjong Solitaire 
Epic tile image height imaged to iPhone at 40cm working distance: 
5 point Verdana font is measured at a standard 1.8797mm.116 
Equation:    tan (5/60) = h/6 
5 point font at 60cm:   tan (x/60) = (1.8797E-3/0.6m) 
    x = 10.76584178’ 
mm height required at 40cm: tan (10.76584178/60) = h/0.4m 
    h = 0.001252667m = 1.2526mm  
    
                                                            
116 Font Size Conversion. Available at: http://unitarium.com/font. Accessed June 23, 2015. 
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Appendix 6 – Distance Pre-Test and Post-Test Graphs 
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Appendix 7 – Binocular and Monocular Post-Test Graphs 
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